Days Speakers Posters Session Type Search
Full screen
List At A Glance
Speaker list
Categories Posters
List
List
Type
Saturday 28 May 12 sessions
    10:00 - 11:15 
    Thyroid Ultrasound Pre Congress course - Session 1
    SAAL 5
    Chairs: Roland Gärtner (Germany) & Ludwig Schaaf (Germany)
    Introduction, ultrasound and other imaging techniques for diagnosis of thyroid disorders
    Markus Luster
    Basics of ultrasonographic  techniques, characteristics of thyroid nodules
    Roland Gärtner
    Role of ultrasonography in autoimmune thyroid disease
    Matthias Schott
    11:15 - 11:30 
    Tea & Coffee
    11:30 - 16:00 
    Thyroid Ultrasound Pre Congress course - Session 2
    SAAL 5
    Chairs: Roland Gärtner (Germany) & Ludwig Schaaf (Germany)
    Ultrasonography in childhood
    Tilman Rohrer
    Indications for fine needle aspiration cytology
    Joachim Feldkamp
    Recent advances in cytology based characterization of thyroid nodules
    Kurt Werner Schmid
    Lunch
    Practical session
    12:00 - 19:30 
    Registration
    ICM Foyer & Exhibition Area
    12:00 - 17:10 
    ECE pre-congress Nurse Course: the care of the patient with Secretory Pituitary Tumours
    12:00 - 14:20 
    ECE pre-congress Nurse Course: Session 1: Diagnosis and treatment
    SAAL 4 A&B
    Chairs: Cecilia Follin (Sweden) & Kathrin Zopf (Germany)
    Registration, lunch, exhibition and posters
    Welcome
    Sofia Llahana
    Diagnosing & treatment of pituitary secreting tumours
    Philippe Chanson
    The role of the endocrine nurse in the pre- and post-operative care of the patient undergoing pituitary surgery
    Sandy Werner
    Questions & Answers with the Panel
    14:20 - 15:50 
    ECE pre-congress Nurse Course: Session 2: Case presentations
    Saal 4 A&B
    Chairs: Cecilia Follin (Sweden) & Kathrin Zopf (Germany)
    The nursing role in long-term follow up of a patient with Cushing’s – a case presentation
    Judith Eck
    The nursing role in longterm follow-up of a patient with acromegaly and in a patient with prolactinoma
    Chris Yedinak (USA), Lisa Shepherd)
    Questions & Answers with the Panel
    Tea & coffee
    15:50 - 17:10 
    ECE pre-congress Nurse Course: Session 3: Long term follow up
    SAAL 4 A&B
    Chairs: Cecilia Follin (Sweden) Kathrin Zopf (Germany) & Melisande Kabala (France)
    Living with Cushing’s
    Stephanie Yin
    Quality of life in patients with pituitary tumours
    Meg Keil
    Nursing educational program
    Alicia Santos
    Questions & Answers with the Panel
    Closing remarks
    Cecilia Follin
    17:30 - 19:30 
    ECE 2016 Opening Ceremony
    Welcome to Munich & ECE 2016
    SAAL 1 MAIN AUDITORIUM
    17:55 - 18:40 
    Geoffrey Harris Prize Lecture
    SAAL 1 MAIN AUDITORIUM
    Chair: AJ van der Lely (The Netherlands)
    GH1
    Beyond the Adenoma Valley: From FIPA to Gigantism and Back
    Albert Beckers (Liège, Belgium)
    18:45 - 19:30 
    European Journal of Endocrinology Prize Lecture
    SAAL 1 MAIN AUDITORIUM
    Chair: Johannes Romijn (The Netherlands)
    EJE1
    Understanding estrogen receptor activity in breast cancer
    Jason Carroll
    19:50 - 21:00 
    Welcome reception
    ICM FOYER & EXHIBITION AREA
Sunday 29 May 32 sessions
    07:30 - 19:30 
    Registration
    ICM FOYER & EXHIBITION AREA
    08:15 - 09:00 
    Meet the Expert 1
    SAAL 5
    Chair: Dimitrios Goulis (Greece)
    Reproductive endocrinology
    MTE1
    Gynaecomastia in adolescents and adults
    Niels Jørgensen
    08:15 - 09:00 
    Meet the Expert 2
    SAAL 13A
    Chair: Ulla Feldt-Rasmussen (Denmark)
    Thyroid
    MTE2.1
    Difficult thyroid cases
    Luca Persani
    MTE2.2
    Difficult thyroid cases
    Carla Moran (Cambridge, United Kingdom)
    08:15 - 09:00 
    Meet the Expert 3
    SAAL 13B
    Chair: Ioannis Ilias (Greece)
    Diabetes Mellitus, obesity and metabolism
    MTE3
    The impact and management of glycaemic control, gestational weight gain and blood pressure on pregnancy outcome in women with diabetes
    Elisabeth Mathiesen
    08:15 - 09:00 
    Debate 1
    SAAL 1 MAIN AUDITORIUM
    Chair: Constantine Stratakis (USA)
    Brain, pituitary, adrenal and neuroendocrine tumours
    D1.1
    The use of NSAIDs in endocrine cancers: the case of Celecoxib: MAYBE
    Noel Clarke
    D1.2
    The use of NSAIDs in endocrine cancers: the case of Celecoxib: FOR
    Joan Carles
    D1.3
    The use of NSAIDs in endocrine cancers: the case of Celecoxib: AGAINST
    Andrea Sacchetti
    08:15 - 09:00 
    New Scientific Approaches 1
    SAAL 4A&B
    Chair: Michaela Luconi (Italy)
    NSA1
    Epigenetic Inheritance in Metabolic Dysfunction
    Romain Barres
    09:15 - 09:45 
    Plenary 1
    SAAL 1 MAIN AUDITORIUM
    Chairs: Marta Korbonits (UK) & Beata Kos-Kudla (Poland)
    PL1
    PRRT, NETTER-1, and the new Era
    Wouter Herder
    09:45 - 10:00 
    Presidential Address & In Memoriam
    SAAL 1 MAIN AUDITORIUM
    Chair: AJ van der Lely (The Netherlands)
    Presidential Address
    In Memoriam - Bruno Allolio
    Wiebke Reincke
    In Memoriam - Jens S Christiansen
    Jens-Otto Jorgensen
    In Memoriam - Mihail Coculescu
    Corin Badiu
    10:00 - 10:30 
    Coffee, Posters & Exhibition
    ICM FOYER & EXHIBITION AREA
    10:30 - 12:00 
    Symposium 1: Thyroid and Pregnancy
    SAAL 5
    Chairs: Tim Korevaar (The Netherlands) & Daniel Glinoer (Belgium)
    Thyroid
    S1.1
    At which TSH cut-off should we start LT4 therapy during pregnancy
    Erik Alexander
    S1.2
    Thyroid auto immunity in relation to assisted reproduction
    Kris Poppe
    S1.3
    How to treat hyperthyroidism during pregnancy
    Peter Laurberg
    10:30 - 12:00 
    Symposium 2: Mixtures, medicines and diet, where now for endocrine disrupting compounds?
    Endorsed by Endocrine Connections
    SAAL 13A
    Chairs: Richard Sharpe (UK) & Paul Fowler (UK)
    Society and the environment
    S2.1
    Real-world chemical mixtures disturb fetal endocrine systems and gonad development in humans and animal models
    Paul Fowler
    S2.2
    Mixture effects of EDCs in animal models
    Ulla Hass
    S2.3
    EDCs: assessing the risks of exposure to environmental chemicals and pharmaceuticals
    Rod Mitchell (Edinburgh, UK)
    10:30 - 12:00 
    Symposium 3: Senescence and plasticity in the anterior pituitary
    SAAL 4A&B
    Chairs: Clara Alvarez (Spain) & Camilla Schalin-Jäntti (Finland)
    Brain, pituitary, adrenal and neuroendocrine tumours
    S3.1
    Programmed cell senescence: IL-6 role in the pituitary
    Eduardo Arzt
    S3.2
    Pituitary stem cells: quest for hidden functions
    Hugo Vankelecom (Leuven, Belgium)
    S3.3
    Stem-progenitor cells in pituitary organ homeostasis and tumorigenesis
    Juan Mertinez-Barbera
    10:30 - 12:00 
    Symposium 4: How to diagnose endocrine disease in obese patients?
    Endorsed by European Journal of Endocrinology
    SAAL 13B
    Chairs: Bernd Schultes (Switzerland) & Erika van de Akker (The Netherlands)
    Diabetes Mellitus, obesity and metabolism
    S4.1
    HPA axis abnormailities and metabolic syndrome
    Eva Kassi
    S4.2
    Male hypogonadism and obesity: How to differentiate cause and consequence
    Felipe Casanueva
    S4.3
    Subclinical hypothyroidism and obesity: cause or consequence?
    Jose Fernandez-Real
    10:30 - 12:00 
    Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
    SAAL 1 MAIN AUDITORIUM
    Chairs: Darko Kastelan (Croatia) & Martin Reincke (Germany)
    Adrenal
    S5.1
    Introduction and presentation of the Guideline Group
    Martin Fassnacht
    S5.2
    Introduction of the methods
    Olaf Dekkers
    S5.3
    Presentation of the four key questions and the respective recommendations: Imaging
    Anju Sahdev
    S5.4
    Presentation of the four key questions and the respective recommendations: Endocrine work-up
    Massimo Terzolo
    S5.5
    Presentation of the four key questions and the respective recommendations: Surgery
    Martin Fassnacht
    S5.6
    Presentation of the four key questions and the respective recommendations: Follow-up
    Antoine Tabarin
    S5.7
    Discussion of the recommendations of special circumstances
    John Newell-Price
    12:00 - 13:30 
    Endocrine nurse session 1: Clinical Symposium 1 – Meet the Nurse Expert
    SAAL 4 A&B
    Chairs: Andrew Dwyer (Switzerland) & Ashley Grossman (UK)
    Neuroendocrine tumours in children
    Kate Davies
    Neuroendocrine tumours in adults
    Trude Haugland
    Genetic considerations of Neuroendocrine tumours
    Kelly Behm
    12:15 - 13:15 
    Oral Communications - Adrenal Basic & Clinical
    SAAL 13A
    Chairs: Garry Hammer (USA) & Wiebke Arlt (UK)
    OC1.1
    Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg Mutation
    Cristina Ronchi
    OC1.2
    Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study
    Guillaume Assie
    OC1.3
    Hormone replacement therapy with prednisolone is associated with a worse lipid profile than replacement with hydrocortisone in patients with adrenal insufficiency: a matched analysis of data from the EU-AIR
    Marcus Quinkler (Berlin, Germany)
    OC1.4
    Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma
    Vasileios Chortis (Birmingham, United Kingdom)
    OC1.5
    Is biochemical assessment of pheochromocytoma necessary in adrenal incidentalomas with magnetic resonance imaging features non-suggestive of pheochromocytoma?
    Sayid Zuhur
    12:15 - 13:15 
    Oral Communication - Receptors & Signalling
    SAAL 13B
    Chairs: Luca Persani (Italy) & Jason Carroll (UK)
    OC2.1
    3-T1AM signaling in the rat thyrocyte cell line PCCL3
    Nancy Schanze
    OC2.2
    Expression levels of thyroglobulin processing proteases are reduced upon trace amine-associated receptor 1 deficiency in mice
    Joanna Szumska
    OC2.3
    PRKACA mutations in adrenal Cushing impair association with the PKA regulatory subunit
    Kerstin Bathon
    OC2.4
    Link between cell cycle, steroidogenesis and PKA in adrenocortical tumors cells.
    Marthe Rizk-Rabin
    OC2.5
    11β-HSD1 is a regulator of brown adipose tissue function and
    Craig Doig
    12:15 - 13:15 
    Oral Communcations - Diabetes Prediction & Complications
    SAAL 1
    Chairs: Florian Kiefer (Austria) & Pierre De Meyts (Belgium)
    OC3.1
    Identification of a spliceosome-associated fingerprint with potential to predict development of type 2 diabetes in high-risk patients
    Justo Castaño
    OC3.2
    Glucose-dependent insulinotropic peptide (GIP) stimulates Glucagon-like peptide (GLP)-1 from human and mouse pancreatic islets partly via alpha-cell-derived IL-6
    Katharina Timper
    OC3.3
    Reproducibility of fasting and oral glucose tolerance test derived parameters of glucose metabolism in non-diabetic postmenopausal women.
    Frederique Velde
    OC3.4
    Association of Neutrophil to Lymphocyte Ratio with Vitamin D Levels in Type 2 Diabetes Mellitus
    Neslihan Atile
    OC3.5
    Improvement In Diabetic Neuropathy After Metabolic Surgery: A Comprehensive Electrophysiological Follow-Up Study
    Eylem Cagiltay
    12:15 - 13:15 
    Oral Communications - Thyroid: Clinical
    SAAL 5
    Chairs: Andrzej Lewinski (Poland) & Peter Laurberg (Denmark)
    OC4.1
    Additional measurement of hCG distinguishes physiological high-normal thyroid function and reveals large differences in the risk of developing preeclampsia.
    Tim Korevaar
    OC4.2
    Molecular fingerprint of experimental thyrotoxicosis on human metabolism: combined metabolome and proteome study
    Maik Pietzner
    OC4.3
    Antibodies against human eye muscle tissue fractions bind to type 2 5’deiodinase and inhibit the lymphocyte MAPK activation derived from hyperthyroid patients with Graves’ disease
    Ildikó Molnár
    OC4.4
    Thyroid function and glucose metabolism in adults after hematopoietic stem cell transplantation
    Delia Bogdanet
    OC4.5
    Risk Factors of Relapse in Graves’ disease? Results from a Systematic Review and Meta-analysis
    Tristan Struja
    13:15 - 14:15 
    Lunch, Posters & Exhibition
    ICM FOYER & EXHIBITION AREA
    13:15 - 14:15 
    Ask the Editor Session
    Professor J A Romijn (European Journal of Endocrinology) and Professor Josef Koehrle (Endocrine Connections)
    ESE stand, booth no. 28
    14:15 - 15:30 
    Endocrine nurse session 2: Professional development session
    SAAL 4 A&B
    Chairs: Sofia Llahana (UK) & Meg Keil (USA)
    Welcome and update from the ESE Nurses Working Group
    Sofia Llahana
    Endocrine nurses’ role in Germany
    Janina Kirchner
    Patient education in Acromegaly. Presentation by winner of Best Nursing Poster Award for ECE 2015
    Els Rutten
    Call for Abstracts, Are you Prepared?
    Meg Keil
    Announcement of Best Nursing Poster Award and short presentation by winner
    TBC
    14:15 - 15:30 
    Industry Sponsored Satellite Symposia
    14:15 - 15:00 
    New Scientific Approaches 2
    SAAL 13B
    Chair: Nadine Binart (France)
    NSA2
    Engineering a functional ovarian transplant
    Monica Laronda
    15:30 - 17:00 
    Symposium 6: Characterisation and treatment of thyroid cancer
    SAAL 1 MAIN AUDITORIUM
    Chairs: Bernadette Biondi (Italy) & Barbara Jarzab (Poland)
    Thyroid
    S6.1
    Intergrated genomic characterisation
    James Fagin (New York, USA))
    S6.2
    Tyrosine Kinase inhibitors for iodine refractory thyroid cancer: what's new?
    Sophie Leboulleux
    S6.3
    Dynamic risk stratification in the follow up of thyroid cancer
    Barbara Jarzab
    15:30 - 17:00 
    Symposium 7: The chronic syndromes of patients with cured pituitary diseases
    Endorsed by European Journal of Endocrinology
    SAAL 5
    Chairs: Alberto Pereira (The Netherlands) & Günter Stalla (Germany)
    Brain, pituitary, adrenal and neuroendocrine tumours
    S7.1
    Acromegaly: 10 years after cure
    Johannes Romijn
    S7.2
    Cushing's disease: 10 years after cure
    Elena Valassi
    S7.3
    Craniopharyngeoma: 10 years after cure
    Hermann Müller
    15:30 - 17:00 
    Symposium 8: Primary aldosteronism
    SAAL 13A
    Chair: Felix Beuschlein (Germany)
    Adrenal
    S8.1
    Novel targets of mineralocorticoid receptor in human renal cells
    Marc Lombes
    S8.2
    Revised guidelines for finding and treating primary aldosteronism
    Franco Mantero
    S8.3
    Adrenal lessons from next-generation sequencing
    Maria-Christina Zennaro
    15:30 - 17:00 
    Symposium 9: Bone marrow adipose tissue - A "novel" functionally active fat depot
    SAAL 13B
    Chairs: Irina Kowalska (Poland) & Dominik Schulte (Germany)
    Diabetes Mellitus, obesity and metabolism
    S9.1
    Bone Marrow Adipose Tisse and bone, a bad romance
    Stephanie Lucas
    S9.2
    Distinct metabolic role of bone marrow adipose tissue
    Riku Kiviranta
    S9.3
    Development, metabolism and endocrine functions of marrow adipose tissues
    Ormond MacDougald
    15:30 - 17:00 
    Symposium 10: Late Breaking News Session
    SAAL 4 A&B
    Chairs: Josef Köhrle (Germany) & Emanuel Christ (Switzerland)
    S10.1
    The Omics of Adrenal Cancer: Answers or more questions?
    Gary Hammer
    S10.2
    Prostate cancer and surrounding fat - a dangerous duo
    Catherine Muller
    S10.3
    The Search for Disease-Causing Mutations in Self-Limited Delayed Puberty
    Sasha Howard
    17:00 - 17:30 
    Coffee, Exhibition & Posters
    ICM FOYER & EXHIBITION AREA
    17:30 - 18:00 
    Plenary 2
    Endorsed by Endocrine Connections
    SAAL 1 MAIN AUDITORIUM
    Chairs: Robin Peeters (The Netherlands) & Jean-Pierre Bourgignon (Belgium)
    PL2
    Endocrine disruptors and the thyroid
    Barbara Demeneix (Paris, France)
    18:00 - 19:30 
    Industry Sponsored Satellite Symposia
Monday 30 May 32 sessions
    07:30 - 18:30 
    Registration
    ICM FOYER & EXHIBITION AREA
    08:15 -  
    New Scientific Approaches 3
    SAAL 4 A&B
    Chair: Ewa Rajpert-De Meyts (Denmark)
    NSA3
    Non-coding RNAs: new hormone-like regulators of signaling pathways
    George Calin
    08:15 - 09:00 
    Meet the Expert 4
    SAAL 5
    Chair: Jens Bollerslev (Norway)
    Calcium and bone
    MTE4
    Treatment of osteoporosis; treatment goals and duration of therapy
    Carola ZiIlikens
    08:15 - 09:00 
    Meet the Expert 5
    SAAL 13A
    Chair: Pierre De Meyts (Belgium)
    Diabetes Mellitus, obesity and metabolism
    MTE5
    SGLT2 inhibitors in the treatment of diabetes
    Thomas Pieber
    08:15 - 09:00 
    Meet the Expert 6
    SAAL 13B
    Chair: Márta Korbonits (UK)
    Brain, pituitary, adrenal and neuroendocrine tumours
    MTE6
    MEN syndromes
    Valeriano Leite
    08:15 - 09:00 
    Debate 2
    Endorsed by European Journal of Endocrinology
    SAAL 1 MAIN AUDITORIUM
    Chair: Stelios Tsagarakis (Greece)
    Adrenal
    D2.1
    Are we ready for pharmacological therapy of obesity?: FOR
    Luc Gaal
    D2.2
    Are we ready for pharmacological therapy of obesity?: AGAINST
    Uberto Pagotto
    09:00 - 09:30 
    Plenary 3
    SAAL 1 MAIN AUDITORIUM
    Chairs: Ilpo Huhtaniemi (Finland/UK) & Eberhard Nieschlag (Germany)
    PL3
    Testosterone trials
    Peter Snyder
    09:30 - 10:00 
    European Hormone Medal Lecture
    SAAL 1 MAIN AUDITORIUM
    Chairs: AJ van der Lely (The Netherlands) & George Mastorakos (Greece)
    EH1
    Obesity
    Felipe Casanueva
    10:00 - 10:30 
    Coffee, Posters & Exhibition
    ICM FOYER & EXHIBITION AREA
    10:30 - 12:00 
    Symposium 11: New Developments in subclinical thyroid disease
    SAAL 5
    Chairs: Laura Fugazzolla (Italy) & Christine Spitzweg (Germany)
    Thyroid
    S11.1
    Thyroid function and aging: what can we learn from animal models?
    Edward Visser (Rotterdam, The Netherlands)
    S11.2
    Subclinical thyroid disease and clinical outcome: lessons from large individual participant-based analyses from the Thyroid Studies Collaboration
    Nicolas Rodondi
    S11.3
    Subclinical hypothyroidism: when should we start treatment
    Leonidas Duntas
    10:30 - 12:00 
    Symposium 12: Novel insights of disorders in pubertal timing
    SAAL 13A
    Chairs: Nelly Pitteloud (Switzerland) & Jacques Young (France)
    Reproductive endocrinology
    S12.1
    Pubertal timing is changing. Possible role for genetic, epigenetic and environmental factors
    Anders Juul (Copenhagen, Denmark)
    S12.2
    Environmental modulation of the pubertal timing and neuroendocrine regulation
    Jean Bourguignon
    S12.3
    Novel regulatory molecules of pubertal timing
    Manuel Tena-Sempere (Córdoba, Spain)
    10:30 - 12:00 
    Symposium 13: Management of Cushing's syndrome
    SAAL 1 MAIN AUDITORIUM
    Chairs: Sabina Zacharieva (Bulgaria) & John Newell-Price (UK)
    Adrenal
    S13.1
    New developments in the medical treatment of Cushing's syndrome
    Richard Feelders
    S13.2
    State of the art treatment in Cushing's disease
    Rosario Pivonello
    S13.3
    Rethinking Familial Adrenal Cushing's
    Maya Lodish
    10:30 - 12:00 
    Symposium 14: Hot topics on vitamin D
    SAAL 13B
    Chairs: Walter Josef Faßbender (Switzerland) & Catalina Poiana (Romania)
    Calcium and bone
    S14.1
    Vitamin D and immunity
    Chantel Mathieu
    S14.2
    Vitamin D and pregnancy - outcomes of mother and child
    Christe Lamberg-Allardt
    S14.3
    CYP24A1 mutations and human disease
    Glenville Jones
    10:30 - 12:00 
    Symposium 15: In the rhythm of EYES: Let's dance!
    SAAL 4 A&B
    Chairs: Elahu Gosney Sustarsic (Denmark) & Ljiljana Marina (Serbia)
    Introduction to EYES and how to join
    Elahu Sustarsic
    S15.1
    The Microbiome Waltz: circadian rhythm of gut microbiota
    Christoph Thaiss
    S15.2
    Jive up your judgement! Density is not the destiny - the lessons from vertebral morphometry and bone turnover in acromegaly
    Marko Stojanovic
    S15.3
    It takes two to tango: Chemokine receptor CXCR4 - important role in human adrenal physiology and tumour disease
    Carmina Fuß
    S15.4
    Belly dancing: The Importance of Maternal Thyroid for the Placental Function
    Mirjana Barjaktarovic
    Invitation to EYES networking event and annual meeting
    Ljiljana Marina
    12:15 - 13:15 
    Oral Communications - Neuroendocrinology
    SAAL 4 A&B
    Chairs: Vallo Volke (Estonia) & Justo Castano (Spain)
    OC5.1
    The Drosophila AIP orthologue is essential for actin cytoskeleton stabilisation and cell adhesion
    Elena Daniela Aflorei
    OC5.2
    Analysis of signal transduction in mice overexpressing mutant versus intact IGFBP-2 identifies a plethora of IGFBP-2 dependent mechanisms in different tissues and suggests permissive or regulatory effects of the RGD-sequence
    Andreas Hoeflich
    OC5.3
    Development of a long-acting growth hormone antagonist for the treatment of acromegaly
    Ian Wilkinson
    OC5.4
    CNS IL-6 Trans-Signaling is enhanced in obese mice to improve anorexigenic and glucoregulatory effects of IL-6
    Katharina Timper
    OC5.5
    Zebrafish tool for the study of prokineticin receptor 2 (PROKR2) pathway on GNRH3 neuronal development
    Ivan Bassi
    12:15 - 13:15 
    Oral Communications - Diabetes therapy & complications
    SAAL 1 MAIN AUDITORIUM
    Chairs: Nevin Dinccag (Turkey) & Klaus Badenhoop (Germany)
    OC6.1
    Choroidal Thickness in Diabetes Mellitus Type 1 Without Clinical Diabetic Retinopathy
    Eylem Cagiltay
    OC6.2
    Cortical bone size deficit in adult patients with type 1 diabetes mellitus.
    Charlotte Verroken
    OC6.3
    TRAIL treatment reduces high-fat diet-induced hyperglycemia and hyperinsulinemia
    Stella Bernardi
    OC6.4
    LEA29Y expression in transgenic porcine islets prevents islet graft rejection in humanized mice without systemic immunosuppressive therapy
    Lelia Wolf-van Buerck
    OC6.5
    Dapagliflozin Added to Lixisenatide in Type 2 Diabetic Patients
    Tomislav Bozek
    12:15 - 13:15 
    Oral Communications - Cardiovascular endocrinology
    SAAL 13A
    Chairs: Luc van Gaal (Belgium) & Franco Mantero (Italy)
    OC7.1
    Lipoprotein lipase DNA methylation: cause or consequence of metabolic disorders
    Daniel Castellano-Castillo
    OC7.2
    Cardiovascular and metabolic morbidity in adult patients with classic congenital adrenal hyperplasia
    Luisa Paizoni
    OC7.3
    Muscle strength in Cushing’s syndrome: cross-sectional evaluation of the German Cushing’s Registry
    Christina Berr
    OC7.4
    Cortisol autonomy is associated with increased risk of cardiovascular events and mortality in patients with adrenal incidentalomas. Beneficial effects of a selective use of adrenalectomy
    Giuseppe Reimondo
    OC7.5
    Hypothyroidism and levothyroxine treatment is associated with increased mortality in heart failure patients
    Mette Andersen
    12:15 - 13:15 
    Oral Communications - Thyroid Translational
    SAAL 13B
    Chairs: Francisco Carrilho (Portugal) & Vincenzo Toscano (Italy)
    OC8.1
    Non-genomic effects of thyroid hormones on endothelial cell tube formation
    Kathrin A. Schmohl
    OC8.2
    Selenium modulates apoptosis in thyroid follicular cells: characterization of molecular mechanisms
    Immacolata Nettore
    OC8.3
    Identification of novel genetic loci associated with thyroid function
    Maja Barbalic
    OC8.4
    Discovering the difference in the tear fluid proteome between Graves` patients with or without orbitopathy
    Milaim Pepaj
    OC8.5
    In vivo effects of repeated thyronamine (T0AM) administration in mice
    Carolin Höfig
    12:15 - 13:15 
    Oral Communications - Endocrine Tumours
    SAAL 5
    Chairs: Natalia Pellegata (Germany) & Catherine Muller (France)
    OC9.1
    Study of new tumor suppressor gene (ZNRF3) in adrenocortical carcinoma
    Omeiri Hanin
    OC9.2
    Role of luteinizing hormone receptor in the ontogeny and progression of adrenocortical tumors in transgenic mice expressing SV40Tag under the inhibin-α promoter
    Milena Doroszko
    OC9.3
    Stressed to death – antioxidant pathway targeting as a novel therapeutic approach in adrenocortical carcinoma
    Vasileios Chortis
    OC9.4
    The truncated somatostatin receptor sst5TMD4 is overexpressed in prostate cancer, where it increases aggressiveness features by regulating key tumor suppressors and oncogenes.
    Raúl Luque
    OC9.5
    Pituicytoma: a neuropathological analysis of 10 samples
    Klaus Mende
    13:15 - 14:15 
    Lunch, Posters & Exhibition
    ICM FOYER & EXHIBITION AREA
    13:30 - 14:00 
    ESE President meets New Members
    Invitation only
    Bistro
    14:00 - 15:30 
    Endocrine nurse session 3: MDT Clinical Symposium 2 – MDT management of Adrenal Insufficiency (AI)
    SAAL 4 A&B
    Chairs: Philip Yeoh (UK) & Paul Carroll (UK)
    Diagnosis and management of AI and adrenal crisis
    Marcus Quinkler (Berlin, Germany)
    Role of the endocrine nurse in patient education and adrenal crisis management
    Smadar Pahl
    Aspects of adherence to medication in AI
    Sarah Chapman
    Development and Progress of the European Adrenal Patient Network and European Emergency Steroid Card
    Jette Kristensen
    Q&A session with the MDT Panel
    14:15 - 15:30 
    Industry Sponsored Satellite Symposia
    14:15 - 15:00 
    Debate 3
    SAAL 13B
    Chair: Ilpo Huhtaniemi (UK/Finland)
    Diabetes Mellitus, obesity and metabolism
    D3.1
    Strengths and weaknesses of hormone immunoassays and mass spectrometry: what the clinician should know: Mass Spectrometry
    Brian Keevil
    D3.2
    Strengths and weaknesses of hormone immunoassays and mass spectrometry: what the clinician should know: Immunoassays
    Outi Itkonen
    15:30 - 17:00 
    Symposium 16: Thyroid nodules
    SAAL 13A
    Chairs: Francesco Latrofa (Italy) & Ludwig Schaaf (Germany)
    Thyroid
    S16.1
    The natural history of the disease
    Sebastiano Filetti
    S16.2
    Peadiatric thyroid nodules
    Marianna Rachmiel
    S16.3
    Molecular diagnosis
    Ralph Paschke
    15:30 - 17:00 
    Symposium 17: Genetics and epigenetics of testicular failure
    SAAL 13B
    Chairs: Manuela Simoni (Italy) & Jörg Gromoll (Germany)
    Reproductive endocrinology
    S17.1
    Aberrations on the X-chromosome as cause of male infertility
    Frank Tüttelmann
    S17.2
    Gene varients modulating testicular function
    Maris Laan
    S17.3
    SEMA3A and SEMA3E: from mice to Kallmann syndrome
    Anna Cariboni (Milan, Italy)
    15:30 - 17:00 
    Symposium 18: Neuroendocrine tumours: new findings, classification and targeted management
    SAAL 1 MAIN AUDITORIUM
    Chairs: Simona Grozinsky-Glasberg (Israel) & Christoph Auernhammer (Germany)
    Brain, pituitary, adrenal and neuroendocrine tumours
    S18.1
    NETs cracking the epigentic code
    Christina Thirlwell
    S18.2
    Current developments in classification of neuroendocrine neoplasia
    Aurel Perren
    S18.3
    Targeted treatment of NETs
    Diego Ferone
    15:30 - 17:00 
    Symposium 19: Brown adipose tissue - a burning issue
    Endorsed by Endocrine Connections
    SAAL 5
    Chairs: Pirjo Nuutila (Finland) & Linda Vignozzi (Italy)
    Diabetes Mellitus, obesity and metabolism
    S19.1
    The role of brown and brite fat in energy balance regulation
    Martin Klingenspor
    S19.2
    Thermogenic programming of adipose tissue
    Florian Kiefer
    S19.3
    Activation of brown adipose tissue
    Patrick Rensen
    15:30 - 17:00 
    Symposium 20: Hitchhiker's guide to the microsmos of GPCRs
    SAAL 4 A&B
    Chairs: Marilyn Theodoropoulou (Germany) & Torsten Schöneberg (Germany)
    Calcium and bone
    S20.1
    Location, location, location: spatial programming of GPCR signalling
    Aylin Hanyaloglu (London, United Kingdom)
    S20.2
    Novel activating mechanism of glycoprotein hormone receptors
    Torsten Schöneberg
    S20.3
    Monomers, dimers or oligomers?
    Jean-Phillippe Pin
    17:00 - 17:30 
    Coffee, Posters & Exhibition
    ICM FOYER & EXHIBITION AREA
    17:30 - 18:00 
    Clinical Endocrinology Trust Lecture
    SAAL 1 MAIN AUDITORIUM
    Chair: Jerome Bertherat (France)
    CETL1
    Adrenal
    Wiebke Arlt
    18:00 - 18:30 
    Plenary 4
    Endorsed by Endocrine Connections
    SAAL 1 MAIN AUDITORIUM
    Chairs: Bulent Yildiz (Turkey) & Christine Kanaka-Gantenbein (Greece)
    PL4
    Gut microbiota, inflammation and metabolism
    Nathalie Delzenne
Tuesday 31 May 30 sessions
    07:30 - 18:00 
    Registration
    ICM FOYER & EXHIBITION AREA
    08:15 - 09:00 
    Meet the Expert 7
    SAAL 5
    Chair: Maria Alevizaki (Greece)
    Thyroid
    MTE7
    Thyroid cancer guidelines: What’s new?
    Furio Pacini
    08:15 - 09:00 
    Meet the Expert 8
    SAAL 13A
    Chair: Misa Pfeifer (Slovenia)
    Society and the environment
    MTE8
    European Medicines Agency: What is on the radar for endocrinologists?
    08:15 - 09:00 
    Meet the Expert 9
    SAAL 13B
    Chair: Andrea Isidori (Italy)
    Reproductive endocrinology
    MTE9
    Management of Male Hypogonadism
    Dimitrios Goulis
    08:15 - 09:00 
    Meet the Expert 10
    SAAL 4 A&B
    Chair: Jochen Schopohl (Germany)
    MTE10
    Systems medicine: the impact on endocrine practice
    Eugenia Resmini
    08:15 - 09:00 
    Debate 4
    SAAL 1 MAIN AUDITORIUM
    Chair: Antoine Tabarin (France)
    D4.1
    Should we treat subclinical Cushing’s syndrome?: FOR
    Massimo Terzolo
    D4.2
    Should we treat subclinical Cushing’s syndrome?: AGAINST
    Paul Stewart
    09:00 - 09:30 
    Plenary 5
    SAAL 1 MAIN AUDITORIUM
    Chairs: Ilpo Huhtaniemi (UK/Finland) & Paolo Beck-Peccoz (Italy)
    PL5
    Receptor research for the drugs of the future
    Martin Lohse
    09:30 - 10:00 
    Coffee, Exhibition & Posters
    ICM FOYER & EXHIBITION AREA
    10:00 - 11:30 
    Symposium 21: An update on hyperparathyroidism
    SAAL 1 MAIN AUDITORIUM
    Chairs: Agnes Linglart (France) & Refik Tanakol (Turkey)
    Thyroid
    S21.1
    Primary hyperparathyroidism: what is new?
    Camilla Schalin-Jäntti
    S21.2
    Hyperparathyroidism, hypertension and hyperaldosteronism
    Evelyn Asbach
    S21.3
    What is new in imaging and surgery for hyperparathyroidism
    Marko Hocevar
    10:00 - 11:30 
    Symposium 22: New mechanisms to induce and and protect from ovarian insuffciency
    SAAL 5
    Chairs: Nadine Binart (France) & Ludwig Wildt (Austria)
    Reproductive endocrinology
    S22.1
    Mammalian ovary
    Kui Liu
    S22.2
    Cohesin ring and primary ovarian insufficiency
    Reiner Veitia
    S22.3
    Ovarian protection during cancer treatment
    Richard Anderson (Edinburgh, UK)
    10:00 - 11:30 
    Symposium 23: Indications of incretin based therapies
    SAAL 13A
    Chairs: Bulent Yildiz (Turkey) & Robert Ritzel (Germany)
    Diabetes Mellitus, obesity and metabolism
    S23.1
    GLP-1 in type 1 diabetic patients
    Thomas Dejgaard
    S23.2
    GLP-1 in type 2 diabetic patients
    Michael Nauck
    S23.3
    GLP-1 in obesity
    Arne Astrup
    10:00 - 11:30 
    Symposium 24: Endocrine neoplasias: new associations
    Endorsed by European Journal of Endocrinology
    SAAL 13B
    Chairs: Maria Chiara Zatelli (Italy) & Maria Tikhomirova (Luxembourg)
    Brain, pituitary, adrenal and neuroendocrine tumours
    S24.1
    Pituitary tumours and succinate dehydrogenase defects
    Paraskevi Xekouki
    S24.2
    Multiple endocrine neoplasia syndromes associated with p27 mutations
    Natalia Pellegata
    S24.3
    Tumours associated with DICER1 mutations
    William Foulkes (Montreal, Canada)
    10:00 - 11:30 
    Symposium 25: What's new and exciting in nuclear receptor action
    SAAL 4 A&B
    Chairs: Jan-Åke Gustafsson (Sweden) & Josef Kohrle (Germany)
    Calcium and bone
    S25.1
    Local regulation of TH action in stem cell survival
    Monica Dentice (Napoli, Italy))
    S25.2
    Ligand independent activity of vitamin D receptor
    Gilles Laverny
    S25.3
    New aspects of glucocorticoid receptor systems
    John Cidlowski (North Carolina, USA)
    11:45 - 12:45 
    Oral Communications - Reproduction & Endocrine Disruption
    SAAL 4 A&B
    Chairs: Joachim Weitzel (Germany) & Andrzej Milewicz (Poland)
    OC10.1
    Systemic enamel pathologies may be due to anti-androgenic effects of some endocrine disruptors
    Katia Jedeon
    OC10.2
    Human luteinizing hormone (hLH) and chorionic gonadotropin (hCG) display biased agonism at the LH/CG receptor
    Laura Riccetti
    OC10.3
    LHCGR signaling promotes gonadal-like cell differentiation and proliferation in gonadectomy-induced adrenocortical tumorigenesis in mice
    Marcin Chrusciel
    OC10.4
    Impaired adipose function in PCOS – evidence that the primary abnormalities are in subcutaneous rather than visceral fat.
    Katarzyna Siemienowicz
    OC10.5
    Effect of clomiphene citrate and metformin on testosterone levels in hypogonadal obese men with impaired glucose tolerance (IGT) or type 2 diabetes (DM2)
    Carla Pelusi
    11:45 - 12:45 
    Oral Communications - Bone & Calcium Homeostasis
    SAAL 13A
    Chairs: Gunter Hofle (Austria) & Dilek Gogas Yavuz (Turkey)
    OC11.1
    An increase of bone mineral density in male-to-female and female-to-male transgender persons after one year cross-sex hormonal treatment
    Chantal Wiepjes
    OC11.2
    Associations of insulin sensitivity with cortical bone geometry in healthy adult men.
    Charlotte Verroken
    OC11.3
    Ultra-trail marathon induces bone response in association with acute and established metabolic changes
    Giovanni Lombardi
    OC11.4
    The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network.
    Francesca Elli
    OC11.5
    Effects of vitamin D supplementation on respiratory muscle strength and physical performance in patients with COPD: a pilot trial.
    Rachida Rafiq
    11:45 - 12:45 
    Oral Communications - Obesity
    SAAL 1
    Chairs: Alper Sonmez (Turkey) & Uberto Pagotto (Georgia)
    OC12.1
    Functional characterization of naturally occurring mutations in the melanocortin receptor accesory protein 2 (MRAP2)
    Heike Biebermann (Berlin, Germany)
    OC12.2
    Female 5β-Reductase Knockout Mice are Protected from Diet Induced Obesity, Insulin Resistance and Glucose Intolerance
    Laura Gathercole
    OC12.3
    Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on circulating pro-neurotensin in the Diet, Obesity, and Genes (DiOGenes) Study: a randomized, controlled trial
    Natalia Rudovich
    OC12.4
    GLP-1 Directed Delivery of Dexamethasone Ameliorates Hypothalamic Inflammation and Reverses Diet-Induced Obesity
    Carmelo Quarta
    OC12.5
    GNB3 overexpression causes obesity and metabolic syndrome
    Alev Ozdemir
    11:45 - 12:45 
    Oral Communications - Pituitary Clinical
    SAAL 5
    Chairs: Svetozar Damjanovic (Serbia) & Zuleyha Karaca (Turkey)
    OC13.1
    Acromegaly is associated with increased cancer risk: a nationwide survey in Italy on behalf of the Italian study group of acromegaly
    Giuseppe Reimondo
    OC13.2
    Growth Hormone and Insulin Signaling After Acute GH Exposure in Patients with Controlled Acromegaly: Impact of Surgery versus Somatostatin Analog Treatment
    Jens Jorgensen
    OC13.3
    Increased Glucocorticoid Replacement Doses are Associated with Excess Mortality in Patients with Non-Functioning Pituitary Adenoma
    Casper Hammarstrand
    OC13.4
    Diagnosis And Management Of Thyrotropin-Secreting Pituitary Tumors: A Single Center Experience With A Long-Term Follow-Up Of 30 Patients
    Oana-Maria Capraru
    OC13.5
    Unmet health and information needs of women with hypogonadotropic hypogonadism
    Andrew Dwyer (Lausanne, Switzerland)
    11:45 - 12:45 
    Oral Communications - Thyroid Cancer
    SAAL 13B
    Chairs: Joao Castro (Portugal) & Klaudia Brix (Germany)
    OC14.1
    Tumor and normal thyroid stem-like cells: from tissues to zebrafish
    Valentina Cirello
    OC14.2
    Complex immunometabolic pathways mediate the interaction between thyroid carcinoma cells and tumor-associated macrophages
    Romana Netea-Maier
    OC14.3
    Tert and The Oxidative Stress In Papillary Thyroid Cancer
    Laura Fugazzola
    OC14.4
    Prognostic value of microscopic extrathyroid extension in papillary thyroid carcinoma
    Bernardo Marques
    OC14.5
    Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma in Germany: a retrospective multi-center study
    Vera Tiedje
    12:45 - 13:45 
    Lunch, Exhibition & Poster Tours
    ICM FOYER & EXHIBITION AREA
    13:00 - 13:40 
    ESE Annual General Meeting
    (ESE members only)
    SAAL 4 A&B
    13:45 - 14:30 
    New Scientific Approaches 4
    SAAL 1 MAIN AUDITORIUM
    Chair: Jochen Seissler (Germany)
    NSA5
    How single cell transcriptomics helps to understand the function of complex endocrine systems
    Stefan Kubicek
    15:00 - 16:30 
    Symposium 26: An update on bone homeostasis and osteoporosis
    Endorsed by European Journal of Endocrinology
    SAAL 5
    Chairs: M Carola Zillikens (The Netherlands) & Geert Carmeliet (Belgium)
    Calcium and bone
    S26.1
    Genetics of human bone formation
    Wim Hul (Antwerp, Belgium)
    S26.2
    Sex steroids and bone metabolism
    Marie Lagerquist
    S26.3
    New bone-forming treatment for osteoporosis
    Socrates Papapoulous
    15:00 - 16:30 
    Symposium 27: Why do we gain weight; homeostasis and rewards of ingestive behaviour
    SAAL 13A
    Chairs: Hendrik Lehnert (Germany) & Andrzej Milewicz (Poland)
    Diabetes Mellitus, obesity and metabolism
    S27.1
    Reward system: the cellular basis
    Lora Heisler
    S27.2
    Brain systems involved in food intake - a neuroimaging approach
    Stefanie Brassen
    S27.3
    TBC
    TBC
    15:00 - 16:30 
    Symposium 28: Adrenal Insufficiency: Causes and management
    SAAL 13B
    Chairs: Stefanie Hahner (Germany) & Andre Lacroix (Canada)
    Adrenal
    S28.1
    TBC
    Stefanie Hahner
    S28.2
    Genetics of adrenal insufficiency
    Christa Flück (Bern, Switzerland)
    S28.3
    Guidelines for dealing with adrenal insufficiency
    Stefan Bornstein
    15:00 - 16:30 
    Symposium 29: New insights into the pathogenesis of PCOS
    SAAL 1 MAIN AUDITORIUM
    Chairs: Stephen Franks (UK) & Vanadin Seifert-Klauss (Germany)
    Reproductive endocrinology
    S29.1
    Metabolic dysfunction in a rodent model of PCOS
    Jenny Visser (Rotterdam, The Netherlands)
    S29.2
    Energy balance and androgens
    Colin Duncan (Edinburgh, UK)
    S29.3
    Have GWAS studies of PCOS given new insights into its pathogenesis
    Cecilia Lindgren
    15:00 - 16:30 
    Symposium 30: Disorders of development and function of neurohypophysis
    SAAL 4 A&B
    Chairs: Emanuel Christ (Switzerland) & Fahrettin Kelestimur (Turkey)
    Brain, pituitary, adrenal and neuroendocrine tumours
    S30.1
    Co-peptin in the diagnosis and prediction of diabetes insipidus
    Mirjam Christ-Crain (Basel, Switzerland)
    S30.2
    Role of TBI in the development of neuropophyseal disorders
    Mark Sherlock (Dublin, Ireland)
    S30.3
    SIADH: current and future management options
    Chris Thompson
    16:30 - 17:00 
    Coffee, Exhibition & Posters
    ICM FOYER & EXHIBITION AREA
    17:00 - 17:15 
    ESE Young Investigator Awards & Poster Prizes
    SAAL 1 MAIN AUDITORIUM
    Chairs: Robin Peeters (The Netherlands), Ewa Rajpert-De Meyts (Denmark) & Filip Gabalec (Czech Republic)
    17:15 - 17:45 
    Plenary 6
    SAAL 1 MAIN AUDITORIUM
    Chairs: Tsvetalina Tankova (Bulgaria) & Sebastian Schmid (Germany)
    PL6
    Bionic pancreas
    Steven Russell
    17:45 - 18:00 
    Closing Ceremony & Invitation to ECE 2017
    SAAL 1 MAIN AUDITORIUM
Guillaume Assie
Guillaume Assie
OC1.2
Sun 29 12:15 Oral Communications - Adrenal Basic & Clinical
Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study
Chantal Wiepjes
Chantal Wiepjes
OC11.1
Tue 31 11:45 Oral Communications - Bone & Calcium Homeostasis
An increase of bone mineral density in male-to-female and female-to-male transgender persons after one year cross-sex hormonal treatment
Stella Bernardi
Stella Bernardi
OC6.3
Mon 30 12:15 Oral Communications - Diabetes therapy & complications
TRAIL treatment reduces high-fat diet-induced hyperglycemia and hyperinsulinemia
Tim Korevaar
Tim Korevaar
OC4.1
Sun 29 12:15 Oral Communications - Thyroid: Clinical
Additional measurement of hCG distinguishes physiological high-normal thyroid function and reveals large differences in the risk of developing preeclampsia.
Niels Jørgensen
Niels Jørgensen
MTE1
Sun 29 08:15 Meet the Expert 1
Gynaecomastia in adolescents and adults
Olaf Dekkers
Olaf Dekkers
S5.2
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Introduction of the methods
Florian Kiefer
Florian Kiefer
S19.2
Mon 30 15:30 Symposium 19: Brown adipose tissue - a burning issue
Thermogenic programming of adipose tissue
Rachida Rafiq
Rachida Rafiq
OC11.5
Tue 31 11:45 Oral Communications - Bone & Calcium Homeostasis
Effects of vitamin D supplementation on respiratory muscle strength and physical performance in patients with COPD: a pilot trial.
Wouter Herder
Wouter Herder
PL1
Sun 29 09:15 Plenary 1
PRRT, NETTER-1, and the new Era
Philippe Chanson
Philippe Chanson
Sat 28 12:00 ECE pre-congress Nurse Course: Session 1: Diagnosis and treatment
Diagnosing & treatment of pituitary secreting tumours
Elena Valassi
Elena Valassi
S7.2
Sun 29 15:30 Symposium 7: The chronic syndromes of patients with cured pituitary diseases
Cushing's disease: 10 years after cure
Rod Mitchell
Rod Mitchell
S2.3
Sun 29 10:30 Symposium 2: Mixtures, medicines and diet, where now for endocrine disrupting compounds?
EDCs: assessing the risks of exposure to environmental chemicals and pharmaceuticals
Anders Juul
Anders Juul
S12.1
Mon 30 10:30 Symposium 12: Novel insights of disorders in pubertal timing
Pubertal timing is changing. Possible role for genetic, epigenetic and environmental factors
John Cidlowski
John Cidlowski
S25.3
Tue 31 10:00 Symposium 25: What's new and exciting in nuclear receptor action
New aspects of glucocorticoid receptor systems
John Newell-Price
John Newell-Price
S5.7
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Discussion of the recommendations of special circumstances
Barbara Demeneix
Barbara Demeneix
PL2
Sun 29 17:30 Plenary 2
Endocrine disruptors and the thyroid
William Foulkes
William Foulkes
S24.3
Tue 31 10:00 Symposium 24: Endocrine neoplasias: new associations
Tumours associated with DICER1 mutations
Richard Feelders
Richard Feelders
S13.1
Mon 30 10:30 Symposium 13: Management of Cushing's syndrome
New developments in the medical treatment of Cushing's syndrome
Diego Ferone
Diego Ferone
S18.3
Mon 30 15:30 Symposium 18: Neuroendocrine tumours: new findings, classification and targeted management
Targeted treatment of NETs
Chris Thompson
Chris Thompson
S30.3
Tue 31 15:00 Symposium 30: Disorders of development and function of neurohypophysis
SIADH: current and future management options
Wim Hul
Wim Hul
S26.1
Tue 31 15:00 Symposium 26: An update on bone homeostasis and osteoporosis
Genetics of human bone formation
Justo Castaño
Justo Castaño
OC3.1
Sun 29 12:15 Oral Communcations - Diabetes Prediction & Complications
Identification of a spliceosome-associated fingerprint with potential to predict development of type 2 diabetes in high-risk patients
Janina Kirchner
Janina Kirchner
Sun 29 14:15 Endocrine nurse session 2: Professional development session
Endocrine nurses’ role in Germany
Cecilia Follin
Cecilia Follin
Sat 28 15:50 ECE pre-congress Nurse Course: Session 3: Long term follow up
Closing remarks
Ivan	Bassi
Ivan Bassi
OC5.5
Mon 30 12:15 Oral Communications - Neuroendocrinology
Zebrafish tool for the study of prokineticin receptor 2 (PROKR2) pathway on GNRH3 neuronal development
Stefan Bornstein
Stefan Bornstein
S28.3
Tue 31 15:00 Symposium 28: Adrenal Insufficiency: Causes and management
Guidelines for dealing with adrenal insufficiency
Markus Luster
Markus Luster
Sat 28 10:00 Thyroid Ultrasound Pre Congress course - Session 1
Introduction, ultrasound and other imaging techniques for diagnosis of thyroid disorders
Sophie Leboulleux
Sophie Leboulleux
S6.2
Sun 29 15:30 Symposium 6: Characterisation and treatment of thyroid cancer
Tyrosine Kinase inhibitors for iodine refractory thyroid cancer: what's new?
Roland Gärtner
Roland Gärtner
Sat 28 10:00 Thyroid Ultrasound Pre Congress course - Session 1
Basics of ultrasonographic  techniques, characteristics of thyroid nodules
Matthias Schott
Matthias Schott
Sat 28 10:00 Thyroid Ultrasound Pre Congress course - Session 1
Role of ultrasonography in autoimmune thyroid disease
Tilman Rohrer
Tilman Rohrer
Sat 28 11:30 Thyroid Ultrasound Pre Congress course - Session 2
Ultrasonography in childhood
Joachim Feldkamp
Joachim Feldkamp
Sat 28 11:30 Thyroid Ultrasound Pre Congress course - Session 2
Indications for fine needle aspiration cytology
Kurt	Werner Schmid
Kurt Werner Schmid
Sat 28 11:30 Thyroid Ultrasound Pre Congress course - Session 2
Recent advances in cytology based characterization of thyroid nodules
Sandy Werner
Sandy Werner
Sat 28 12:00 ECE pre-congress Nurse Course: Session 1: Diagnosis and treatment
The role of the endocrine nurse in the pre- and post-operative care of the patient undergoing pituitary surgery
Judith Eck
Judith Eck
Sat 28 14:20 ECE pre-congress Nurse Course: Session 2: Case presentations
The nursing role in long-term follow up of a patient with Cushing’s – a case presentation
Stephanie Yin
Stephanie Yin
Sat 28 15:50 ECE pre-congress Nurse Course: Session 3: Long term follow up
Living with Cushing’s
Meg Keil
Meg Keil
Sat 28 15:50 ECE pre-congress Nurse Course: Session 3: Long term follow up
Quality of life in patients with pituitary tumours
Meg Keil
Meg Keil
Sun 29 14:15 Endocrine nurse session 2: Professional development session
Call for Abstracts, Are you Prepared?
Alicia Santos
Alicia Santos
Sat 28 15:50 ECE pre-congress Nurse Course: Session 3: Long term follow up
Nursing educational program
Luca Persani
Luca Persani
MTE2.1
Sun 29 08:15 Meet the Expert 2
Difficult thyroid cases
Elisabeth Mathiesen
Elisabeth Mathiesen
MTE3
Sun 29 08:15 Meet the Expert 3
The impact and management of glycaemic control, gestational weight gain and blood pressure on pregnancy outcome in women with diabetes
Noel Clarke
Noel Clarke
D1.1
Sun 29 08:15 Debate 1
The use of NSAIDs in endocrine cancers: the case of Celecoxib: MAYBE
Joan Carles
Joan Carles
D1.2
Sun 29 08:15 Debate 1
The use of NSAIDs in endocrine cancers: the case of Celecoxib: FOR
Andrea Sacchetti
Andrea Sacchetti
D1.3
Sun 29 08:15 Debate 1
The use of NSAIDs in endocrine cancers: the case of Celecoxib: AGAINST
Romain Barres
Romain Barres
NSA1
Sun 29 08:15 New Scientific Approaches 1
Epigenetic Inheritance in Metabolic Dysfunction
Wiebke Reincke
Wiebke Reincke
Sun 29 09:45 Presidential Address & In Memoriam
In Memoriam - Bruno Allolio
Jens-Otto Jorgensen
Jens-Otto Jorgensen
Sun 29 09:45 Presidential Address & In Memoriam
In Memoriam - Jens S Christiansen
Corin Badiu
Corin Badiu
Sun 29 09:45 Presidential Address & In Memoriam
In Memoriam - Mihail Coculescu
Erik Alexander
Erik Alexander
S1.1
Sun 29 10:30 Symposium 1: Thyroid and Pregnancy
At which TSH cut-off should we start LT4 therapy during pregnancy
Kris Poppe
Kris Poppe
S1.2
Sun 29 10:30 Symposium 1: Thyroid and Pregnancy
Thyroid auto immunity in relation to assisted reproduction
Peter Laurberg
Peter Laurberg
S1.3
Sun 29 10:30 Symposium 1: Thyroid and Pregnancy
How to treat hyperthyroidism during pregnancy
Paul Fowler
Paul Fowler
S2.1
Sun 29 10:30 Symposium 2: Mixtures, medicines and diet, where now for endocrine disrupting compounds?
Real-world chemical mixtures disturb fetal endocrine systems and gonad development in humans and animal models
Ulla Hass
Ulla Hass
S2.2
Sun 29 10:30 Symposium 2: Mixtures, medicines and diet, where now for endocrine disrupting compounds?
Mixture effects of EDCs in animal models
Eduardo Arzt
Eduardo Arzt
S3.1
Sun 29 10:30 Symposium 3: Senescence and plasticity in the anterior pituitary
Programmed cell senescence: IL-6 role in the pituitary
Juan Mertinez-Barbera
Juan Mertinez-Barbera
S3.3
Sun 29 10:30 Symposium 3: Senescence and plasticity in the anterior pituitary
Stem-progenitor cells in pituitary organ homeostasis and tumorigenesis
Eva Kassi
Eva Kassi
S4.1
Sun 29 10:30 Symposium 4: How to diagnose endocrine disease in obese patients?
HPA axis abnormailities and metabolic syndrome
Jose Fernandez-Real
Jose Fernandez-Real
S4.3
Sun 29 10:30 Symposium 4: How to diagnose endocrine disease in obese patients?
Subclinical hypothyroidism and obesity: cause or consequence?
Martin Fassnacht
Martin Fassnacht
S5.1
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Introduction and presentation of the Guideline Group
Martin Fassnacht
Martin Fassnacht
S5.5
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Presentation of the four key questions and the respective recommendations: Surgery
Anju	Sahdev
Anju Sahdev
S5.3
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Presentation of the four key questions and the respective recommendations: Imaging
Massimo Terzolo
Massimo Terzolo
S5.4
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Presentation of the four key questions and the respective recommendations: Endocrine work-up
Massimo Terzolo
Massimo Terzolo
D4.1
Tue 31 08:15 Debate 4
Should we treat subclinical Cushing’s syndrome?: FOR
Antoine Tabarin
Antoine Tabarin
S5.6
Sun 29 10:30 Symposium 5: ESE clinical guidelines: Management of adrenal incidentaloma
Presentation of the four key questions and the respective recommendations: Follow-up
Kate	Davies
Kate Davies
Sun 29 12:00 Endocrine nurse session 1: Clinical Symposium 1 – Meet the Nurse Expert
Neuroendocrine tumours in children
Trude Haugland
Trude Haugland
Sun 29 12:00 Endocrine nurse session 1: Clinical Symposium 1 – Meet the Nurse Expert
Neuroendocrine tumours in adults
Kelly	Behm
Kelly Behm
Sun 29 12:00 Endocrine nurse session 1: Clinical Symposium 1 – Meet the Nurse Expert
Genetic considerations of Neuroendocrine tumours
Sayid Zuhur
Sayid Zuhur
OC1.5
Sun 29 12:15 Oral Communications - Adrenal Basic & Clinical
Is biochemical assessment of pheochromocytoma necessary in adrenal incidentalomas with magnetic resonance imaging features non-suggestive of pheochromocytoma?
Nancy Schanze
Nancy Schanze
OC2.1
Sun 29 12:15 Oral Communication - Receptors & Signalling
3-T1AM signaling in the rat thyrocyte cell line PCCL3
Joanna Szumska
Joanna Szumska
OC2.2
Sun 29 12:15 Oral Communication - Receptors & Signalling
Expression levels of thyroglobulin processing proteases are reduced upon trace amine-associated receptor 1 deficiency in mice
Kerstin Bathon
Kerstin Bathon
OC2.3
Sun 29 12:15 Oral Communication - Receptors & Signalling
PRKACA mutations in adrenal Cushing impair association with the PKA regulatory subunit
Marthe Rizk-Rabin
Marthe Rizk-Rabin
OC2.4
Sun 29 12:15 Oral Communication - Receptors & Signalling
Link between cell cycle, steroidogenesis and PKA in adrenocortical tumors cells.
Craig Doig
Craig Doig
OC2.5
Sun 29 12:15 Oral Communication - Receptors & Signalling
11β-HSD1 is a regulator of brown adipose tissue function and
Katharina	Timper
Katharina Timper
OC3.2
Sun 29 12:15 Oral Communcations - Diabetes Prediction & Complications
Glucose-dependent insulinotropic peptide (GIP) stimulates Glucagon-like peptide (GLP)-1 from human and mouse pancreatic islets partly via alpha-cell-derived IL-6
Katharina	Timper
Katharina Timper
OC5.4
Mon 30 12:15 Oral Communications - Neuroendocrinology
CNS IL-6 Trans-Signaling is enhanced in obese mice to improve anorexigenic and glucoregulatory effects of IL-6
Frederique Velde
Frederique Velde
OC3.3
Sun 29 12:15 Oral Communcations - Diabetes Prediction & Complications
Reproducibility of fasting and oral glucose tolerance test derived parameters of glucose metabolism in non-diabetic postmenopausal women.
Neslihan Atile
Neslihan Atile
OC3.4
Sun 29 12:15 Oral Communcations - Diabetes Prediction & Complications
Association of Neutrophil to Lymphocyte Ratio with Vitamin D Levels in Type 2 Diabetes Mellitus
Eylem Cagiltay
Eylem Cagiltay
OC3.5
Sun 29 12:15 Oral Communcations - Diabetes Prediction & Complications
Improvement In Diabetic Neuropathy After Metabolic Surgery: A Comprehensive Electrophysiological Follow-Up Study
Eylem Cagiltay
Eylem Cagiltay
OC6.1
Mon 30 12:15 Oral Communications - Diabetes therapy & complications
Choroidal Thickness in Diabetes Mellitus Type 1 Without Clinical Diabetic Retinopathy
Maik	Pietzner
Maik Pietzner
OC4.2
Sun 29 12:15 Oral Communications - Thyroid: Clinical
Molecular fingerprint of experimental thyrotoxicosis on human metabolism: combined metabolome and proteome study
Ildikó Molnár
Ildikó Molnár
OC4.3
Sun 29 12:15 Oral Communications - Thyroid: Clinical
Antibodies against human eye muscle tissue fractions bind to type 2 5’deiodinase and inhibit the lymphocyte MAPK activation derived from hyperthyroid patients with Graves’ disease
Delia Bogdanet
Delia Bogdanet
OC4.4
Sun 29 12:15 Oral Communications - Thyroid: Clinical
Thyroid function and glucose metabolism in adults after hematopoietic stem cell transplantation
Tristan Struja
Tristan Struja
OC4.5
Sun 29 12:15 Oral Communications - Thyroid: Clinical
Risk Factors of Relapse in Graves’ disease? Results from a Systematic Review and Meta-analysis
Els Rutten
Els Rutten
Sun 29 14:15 Endocrine nurse session 2: Professional development session
Patient education in Acromegaly. Presentation by winner of Best Nursing Poster Award for ECE 2015
Monica Laronda
Monica Laronda
NSA2
Sun 29 14:15 New Scientific Approaches 2
Engineering a functional ovarian transplant
Barbara Jarzab
Barbara Jarzab
S6.3
Sun 29 15:30 Symposium 6: Characterisation and treatment of thyroid cancer
Dynamic risk stratification in the follow up of thyroid cancer
Johannes Romijn
Johannes Romijn
S7.1
Sun 29 15:30 Symposium 7: The chronic syndromes of patients with cured pituitary diseases
Acromegaly: 10 years after cure
Hermann Müller
Hermann Müller
S7.3
Sun 29 15:30 Symposium 7: The chronic syndromes of patients with cured pituitary diseases
Craniopharyngeoma: 10 years after cure
Marc Lombes
Marc Lombes
S8.1
Sun 29 15:30 Symposium 8: Primary aldosteronism
Novel targets of mineralocorticoid receptor in human renal cells
Franco Mantero
Franco Mantero
S8.2
Sun 29 15:30 Symposium 8: Primary aldosteronism
Revised guidelines for finding and treating primary aldosteronism
Maria-Christina Zennaro
Maria-Christina Zennaro
S8.3
Sun 29 15:30 Symposium 8: Primary aldosteronism
Adrenal lessons from next-generation sequencing
Stephanie Lucas
Stephanie Lucas
S9.1
Sun 29 15:30 Symposium 9: Bone marrow adipose tissue - A "novel" functionally active fat depot
Bone Marrow Adipose Tisse and bone, a bad romance
Riku Kiviranta
Riku Kiviranta
S9.2
Sun 29 15:30 Symposium 9: Bone marrow adipose tissue - A "novel" functionally active fat depot
Distinct metabolic role of bone marrow adipose tissue
Ormond MacDougald
Ormond MacDougald
S9.3
Sun 29 15:30 Symposium 9: Bone marrow adipose tissue - A "novel" functionally active fat depot
Development, metabolism and endocrine functions of marrow adipose tissues
Gary Hammer
Gary Hammer
S10.1
Sun 29 15:30 Symposium 10: Late Breaking News Session
The Omics of Adrenal Cancer: Answers or more questions?
Catherine	Muller
Catherine Muller
S10.2
Sun 29 15:30 Symposium 10: Late Breaking News Session
Prostate cancer and surrounding fat - a dangerous duo
George Calin
George Calin
NSA3
Mon 30 08:15 New Scientific Approaches 3
Non-coding RNAs: new hormone-like regulators of signaling pathways
Carola ZiIlikens
Carola ZiIlikens
MTE4
Mon 30 08:15 Meet the Expert 4
Treatment of osteoporosis; treatment goals and duration of therapy
Thomas Pieber
Thomas Pieber
MTE5
Mon 30 08:15 Meet the Expert 5
SGLT2 inhibitors in the treatment of diabetes
Valeriano Leite
Valeriano Leite
MTE6
Mon 30 08:15 Meet the Expert 6
MEN syndromes
Luc Gaal
Luc Gaal
D2.1
Mon 30 08:15 Debate 2
Are we ready for pharmacological therapy of obesity?: FOR
Uberto Pagotto
Uberto Pagotto
D2.2
Mon 30 08:15 Debate 2
Are we ready for pharmacological therapy of obesity?: AGAINST
Peter Snyder
Peter Snyder
PL3
Mon 30 09:00 Plenary 3
Testosterone trials
Nicolas Rodondi
Nicolas Rodondi
S11.2
Mon 30 10:30 Symposium 11: New Developments in subclinical thyroid disease
Subclinical thyroid disease and clinical outcome: lessons from large individual participant-based analyses from the Thyroid Studies Collaboration
Leonidas Duntas
Leonidas Duntas
S11.3
Mon 30 10:30 Symposium 11: New Developments in subclinical thyroid disease
Subclinical hypothyroidism: when should we start treatment
Jean Bourguignon
Jean Bourguignon
S12.2
Mon 30 10:30 Symposium 12: Novel insights of disorders in pubertal timing
Environmental modulation of the pubertal timing and neuroendocrine regulation
Maya Lodish
Maya Lodish
S13.3
Mon 30 10:30 Symposium 13: Management of Cushing's syndrome
Rethinking Familial Adrenal Cushing's
Chantel Mathieu
Chantel Mathieu
S14.1
Mon 30 10:30 Symposium 14: Hot topics on vitamin D
Vitamin D and immunity
Christe Lamberg-Allardt
Christe Lamberg-Allardt
S14.2
Mon 30 10:30 Symposium 14: Hot topics on vitamin D
Vitamin D and pregnancy - outcomes of mother and child
Glenville Jones
Glenville Jones
S14.3
Mon 30 10:30 Symposium 14: Hot topics on vitamin D
CYP24A1 mutations and human disease
Elahu Sustarsic
Elahu Sustarsic
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
Introduction to EYES and how to join
Christoph	Thaiss
Christoph Thaiss
S15.1
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
The Microbiome Waltz: circadian rhythm of gut microbiota
Marko Stojanovic
Marko Stojanovic
S15.2
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
Jive up your judgement! Density is not the destiny - the lessons from vertebral morphometry and bone turnover in acromegaly
Carmina Fuß
Carmina Fuß
S15.3
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
It takes two to tango: Chemokine receptor CXCR4 - important role in human adrenal physiology and tumour disease
Mirjana Barjaktarovic
Mirjana Barjaktarovic
S15.4
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
Belly dancing: The Importance of Maternal Thyroid for the Placental Function
Ljiljana Marina
Ljiljana Marina
Mon 30 10:30 Symposium 15: In the rhythm of EYES: Let's dance!
Invitation to EYES networking event and annual meeting
Elena Daniela	Aflorei
Elena Daniela Aflorei
OC5.1
Mon 30 12:15 Oral Communications - Neuroendocrinology
The Drosophila AIP orthologue is essential for actin cytoskeleton stabilisation and cell adhesion
Andreas Hoeflich
Andreas Hoeflich
OC5.2
Mon 30 12:15 Oral Communications - Neuroendocrinology
Analysis of signal transduction in mice overexpressing mutant versus intact IGFBP-2 identifies a plethora of IGFBP-2 dependent mechanisms in different tissues and suggests permissive or regulatory effects of the RGD-sequence
Ian Wilkinson
Ian Wilkinson
OC5.3
Mon 30 12:15 Oral Communications - Neuroendocrinology
Development of a long-acting growth hormone antagonist for the treatment of acromegaly
Charlotte	Verroken
Charlotte Verroken
OC6.2
Mon 30 12:15 Oral Communications - Diabetes therapy & complications
Cortical bone size deficit in adult patients with type 1 diabetes mellitus.
Charlotte	Verroken
Charlotte Verroken
OC11.2
Tue 31 11:45 Oral Communications - Bone & Calcium Homeostasis
Associations of insulin sensitivity with cortical bone geometry in healthy adult men.
Lelia	Wolf-van Buerck
Lelia Wolf-van Buerck
OC6.4
Mon 30 12:15 Oral Communications - Diabetes therapy & complications
LEA29Y expression in transgenic porcine islets prevents islet graft rejection in humanized mice without systemic immunosuppressive therapy
Tomislav	Bozek
Tomislav Bozek
OC6.5
Mon 30 12:15 Oral Communications - Diabetes therapy & complications
Dapagliflozin Added to Lixisenatide in Type 2 Diabetic Patients
Daniel Castellano-Castillo
Daniel Castellano-Castillo
OC7.1
Mon 30 12:15 Oral Communications - Cardiovascular endocrinology
Lipoprotein lipase DNA methylation: cause or consequence of metabolic disorders
Luisa Paizoni
Luisa Paizoni
OC7.2
Mon 30 12:15 Oral Communications - Cardiovascular endocrinology
Cardiovascular and metabolic morbidity in adult patients with classic congenital adrenal hyperplasia
Christina Berr
Christina Berr
OC7.3
Mon 30 12:15 Oral Communications - Cardiovascular endocrinology
Muscle strength in Cushing’s syndrome: cross-sectional evaluation of the German Cushing’s Registry
Giuseppe	Reimondo
Giuseppe Reimondo
OC7.4
Mon 30 12:15 Oral Communications - Cardiovascular endocrinology
Cortisol autonomy is associated with increased risk of cardiovascular events and mortality in patients with adrenal incidentalomas. Beneficial effects of a selective use of adrenalectomy
Giuseppe	Reimondo
Giuseppe Reimondo
OC13.1
Tue 31 11:45 Oral Communications - Pituitary Clinical
Acromegaly is associated with increased cancer risk: a nationwide survey in Italy on behalf of the Italian study group of acromegaly
Mette Andersen
Mette Andersen
OC7.5
Mon 30 12:15 Oral Communications - Cardiovascular endocrinology
Hypothyroidism and levothyroxine treatment is associated with increased mortality in heart failure patients
Kathrin A.	Schmohl
Kathrin A. Schmohl
OC8.1
Mon 30 12:15 Oral Communications - Thyroid Translational
Non-genomic effects of thyroid hormones on endothelial cell tube formation
Immacolata Nettore
Immacolata Nettore
OC8.2
Mon 30 12:15 Oral Communications - Thyroid Translational
Selenium modulates apoptosis in thyroid follicular cells: characterization of molecular mechanisms
Maja Barbalic
Maja Barbalic
OC8.3
Mon 30 12:15 Oral Communications - Thyroid Translational
Identification of novel genetic loci associated with thyroid function
Milaim Pepaj
Milaim Pepaj
OC8.4
Mon 30 12:15 Oral Communications - Thyroid Translational
Discovering the difference in the tear fluid proteome between Graves` patients with or without orbitopathy
Carolin Höfig
Carolin Höfig
OC8.5
Mon 30 12:15 Oral Communications - Thyroid Translational
In vivo effects of repeated thyronamine (T0AM) administration in mice
Omeiri Hanin
Omeiri Hanin
OC9.1
Mon 30 12:15 Oral Communications - Endocrine Tumours
Study of new tumor suppressor gene (ZNRF3) in adrenocortical carcinoma
Milena Doroszko
Milena Doroszko
OC9.2
Mon 30 12:15 Oral Communications - Endocrine Tumours
Role of luteinizing hormone receptor in the ontogeny and progression of adrenocortical tumors in transgenic mice expressing SV40Tag under the inhibin-α promoter
Vasileios	Chortis
Vasileios Chortis
OC9.3
Mon 30 12:15 Oral Communications - Endocrine Tumours
Stressed to death – antioxidant pathway targeting as a novel therapeutic approach in adrenocortical carcinoma
Raúl Luque
Raúl Luque
OC9.4
Mon 30 12:15 Oral Communications - Endocrine Tumours
The truncated somatostatin receptor sst5TMD4 is overexpressed in prostate cancer, where it increases aggressiveness features by regulating key tumor suppressors and oncogenes.
Klaus Mende
Klaus Mende
OC9.5
Mon 30 12:15 Oral Communications - Endocrine Tumours
Pituicytoma: a neuropathological analysis of 10 samples
Smadar Pahl
Smadar Pahl
Mon 30 14:00 Endocrine nurse session 3: MDT Clinical Symposium 2 – MDT management of Adrenal Insufficiency (AI)
Role of the endocrine nurse in patient education and adrenal crisis management
Sarah Chapman
Sarah Chapman
Mon 30 14:00 Endocrine nurse session 3: MDT Clinical Symposium 2 – MDT management of Adrenal Insufficiency (AI)
Aspects of adherence to medication in AI
Jette	Kristensen
Jette Kristensen
Mon 30 14:00 Endocrine nurse session 3: MDT Clinical Symposium 2 – MDT management of Adrenal Insufficiency (AI)
Development and Progress of the European Adrenal Patient Network and European Emergency Steroid Card
Brian Keevil
Brian Keevil
D3.1
Mon 30 14:15 Debate 3
Strengths and weaknesses of hormone immunoassays and mass spectrometry: what the clinician should know: Mass Spectrometry
Outi Itkonen
Outi Itkonen
D3.2
Mon 30 14:15 Debate 3
Strengths and weaknesses of hormone immunoassays and mass spectrometry: what the clinician should know: Immunoassays
Sebastiano Filetti
Sebastiano Filetti
S16.1
Mon 30 15:30 Symposium 16: Thyroid nodules
The natural history of the disease
Marianna Rachmiel
Marianna Rachmiel
S16.2
Mon 30 15:30 Symposium 16: Thyroid nodules
Peadiatric thyroid nodules
Ralph Paschke
Ralph Paschke
S16.3
Mon 30 15:30 Symposium 16: Thyroid nodules
Molecular diagnosis
Frank Tüttelmann
Frank Tüttelmann
S17.1
Mon 30 15:30 Symposium 17: Genetics and epigenetics of testicular failure
Aberrations on the X-chromosome as cause of male infertility
Maris Laan
Maris Laan
S17.2
Mon 30 15:30 Symposium 17: Genetics and epigenetics of testicular failure
Gene varients modulating testicular function
Aurel Perren
Aurel Perren
S18.2
Mon 30 15:30 Symposium 18: Neuroendocrine tumours: new findings, classification and targeted management
Current developments in classification of neuroendocrine neoplasia
Martin Klingenspor
Martin Klingenspor
S19.1
Mon 30 15:30 Symposium 19: Brown adipose tissue - a burning issue
The role of brown and brite fat in energy balance regulation
Patrick Rensen
Patrick Rensen
S19.3
Mon 30 15:30 Symposium 19: Brown adipose tissue - a burning issue
Activation of brown adipose tissue
Torsten Schöneberg
Torsten Schöneberg
S20.2
Mon 30 15:30 Symposium 20: Hitchhiker's guide to the microsmos of GPCRs
Novel activating mechanism of glycoprotein hormone receptors
Jean-Phillippe Pin
Jean-Phillippe Pin
S20.3
Mon 30 15:30 Symposium 20: Hitchhiker's guide to the microsmos of GPCRs
Monomers, dimers or oligomers?
Nathalie Delzenne
Nathalie Delzenne
PL4
Mon 30 18:00 Plenary 4
Gut microbiota, inflammation and metabolism
Furio Pacini
Furio Pacini
MTE7
Tue 31 08:15 Meet the Expert 7
Thyroid cancer guidelines: What’s new?
Dimitrios Goulis
Dimitrios Goulis
MTE9
Tue 31 08:15 Meet the Expert 9
Management of Male Hypogonadism
Eugenia Resmini
Eugenia Resmini
MTE10
Tue 31 08:15 Meet the Expert 10
Systems medicine: the impact on endocrine practice
Martin Lohse
Martin Lohse
PL5
Tue 31 09:00 Plenary 5
Receptor research for the drugs of the future
Camilla Schalin-Jäntti
Camilla Schalin-Jäntti
S21.1
Tue 31 10:00 Symposium 21: An update on hyperparathyroidism
Primary hyperparathyroidism: what is new?
Evelyn Asbach
Evelyn Asbach
S21.2
Tue 31 10:00 Symposium 21: An update on hyperparathyroidism
Hyperparathyroidism, hypertension and hyperaldosteronism
Marko Hocevar
Marko Hocevar
S21.3
Tue 31 10:00 Symposium 21: An update on hyperparathyroidism
What is new in imaging and surgery for hyperparathyroidism
Kui Liu
Kui Liu
S22.1
Tue 31 10:00 Symposium 22: New mechanisms to induce and and protect from ovarian insuffciency
Mammalian ovary
Reiner Veitia
Reiner Veitia
S22.2
Tue 31 10:00 Symposium 22: New mechanisms to induce and and protect from ovarian insuffciency
Cohesin ring and primary ovarian insufficiency
Thomas Dejgaard
Thomas Dejgaard
S23.1
Tue 31 10:00 Symposium 23: Indications of incretin based therapies
GLP-1 in type 1 diabetic patients
Michael Nauck
Michael Nauck
S23.2
Tue 31 10:00 Symposium 23: Indications of incretin based therapies
GLP-1 in type 2 diabetic patients
Arne Astrup
Arne Astrup
S23.3
Tue 31 10:00 Symposium 23: Indications of incretin based therapies
GLP-1 in obesity
Paraskevi Xekouki
Paraskevi Xekouki
S24.1
Tue 31 10:00 Symposium 24: Endocrine neoplasias: new associations
Pituitary tumours and succinate dehydrogenase defects
Natalia Pellegata
Natalia Pellegata
S24.2
Tue 31 10:00 Symposium 24: Endocrine neoplasias: new associations
Multiple endocrine neoplasia syndromes associated with p27 mutations
Gilles Laverny
Gilles Laverny
S25.2
Tue 31 10:00 Symposium 25: What's new and exciting in nuclear receptor action
Ligand independent activity of vitamin D receptor
Katia Jedeon
Katia Jedeon
OC10.1
Tue 31 11:45 Oral Communications - Reproduction & Endocrine Disruption
Systemic enamel pathologies may be due to anti-androgenic effects of some endocrine disruptors
Laura Riccetti
Laura Riccetti
OC10.2
Tue 31 11:45 Oral Communications - Reproduction & Endocrine Disruption
Human luteinizing hormone (hLH) and chorionic gonadotropin (hCG) display biased agonism at the LH/CG receptor
Marcin Chrusciel
Marcin Chrusciel
OC10.3
Tue 31 11:45 Oral Communications - Reproduction & Endocrine Disruption
LHCGR signaling promotes gonadal-like cell differentiation and proliferation in gonadectomy-induced adrenocortical tumorigenesis in mice
Katarzyna Siemienowicz
Katarzyna Siemienowicz
OC10.4
Tue 31 11:45 Oral Communications - Reproduction & Endocrine Disruption
Impaired adipose function in PCOS – evidence that the primary abnormalities are in subcutaneous rather than visceral fat.
Carla Pelusi
Carla Pelusi
OC10.5
Tue 31 11:45 Oral Communications - Reproduction & Endocrine Disruption
Effect of clomiphene citrate and metformin on testosterone levels in hypogonadal obese men with impaired glucose tolerance (IGT) or type 2 diabetes (DM2)
Giovanni	Lombardi
Giovanni Lombardi
OC11.3
Tue 31 11:45 Oral Communications - Bone & Calcium Homeostasis
Ultra-trail marathon induces bone response in association with acute and established metabolic changes
Francesca Elli
Francesca Elli
OC11.4
Tue 31 11:45 Oral Communications - Bone & Calcium Homeostasis
The prevalence of GNAS deficiency-related diseases in a large cohort of patients characterized by the EuroPHP network.
Heike Biebermann
Heike Biebermann
OC12.1
Tue 31 11:45 Oral Communications - Obesity
Functional characterization of naturally occurring mutations in the melanocortin receptor accesory protein 2 (MRAP2)
Natalia Rudovich
Natalia Rudovich
OC12.3
Tue 31 11:45 Oral Communications - Obesity
Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on circulating pro-neurotensin in the Diet, Obesity, and Genes (DiOGenes) Study: a randomized, controlled trial
Carmelo Quarta
Carmelo Quarta
OC12.4
Tue 31 11:45 Oral Communications - Obesity
GLP-1 Directed Delivery of Dexamethasone Ameliorates Hypothalamic Inflammation and Reverses Diet-Induced Obesity
Alev Ozdemir
Alev Ozdemir
OC12.5
Tue 31 11:45 Oral Communications - Obesity
GNB3 overexpression causes obesity and metabolic syndrome
Jens Jorgensen
Jens Jorgensen
OC13.2
Tue 31 11:45 Oral Communications - Pituitary Clinical
Growth Hormone and Insulin Signaling After Acute GH Exposure in Patients with Controlled Acromegaly: Impact of Surgery versus Somatostatin Analog Treatment
Casper Hammarstrand
Casper Hammarstrand
OC13.3
Tue 31 11:45 Oral Communications - Pituitary Clinical
Increased Glucocorticoid Replacement Doses are Associated with Excess Mortality in Patients with Non-Functioning Pituitary Adenoma
Oana-Maria Capraru
Oana-Maria Capraru
OC13.4
Tue 31 11:45 Oral Communications - Pituitary Clinical
Diagnosis And Management Of Thyrotropin-Secreting Pituitary Tumors: A Single Center Experience With A Long-Term Follow-Up Of 30 Patients
Valentina	Cirello
Valentina Cirello
OC14.1
Tue 31 11:45 Oral Communications - Thyroid Cancer
Tumor and normal thyroid stem-like cells: from tissues to zebrafish
Bernardo	Marques
Bernardo Marques
OC14.4
Tue 31 11:45 Oral Communications - Thyroid Cancer
Prognostic value of microscopic extrathyroid extension in papillary thyroid carcinoma
Vera	Tiedje
Vera Tiedje
OC14.5
Tue 31 11:45 Oral Communications - Thyroid Cancer
Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma in Germany: a retrospective multi-center study
Stefan Kubicek
Stefan Kubicek
NSA5
Tue 31 13:45 New Scientific Approaches 4
How single cell transcriptomics helps to understand the function of complex endocrine systems
Marie Lagerquist
Marie Lagerquist
S26.2
Tue 31 15:00 Symposium 26: An update on bone homeostasis and osteoporosis
Sex steroids and bone metabolism
Socrates Papapoulous
Socrates Papapoulous
S26.3
Tue 31 15:00 Symposium 26: An update on bone homeostasis and osteoporosis
New bone-forming treatment for osteoporosis
Stefanie Brassen
Stefanie Brassen
S27.2
Tue 31 15:00 Symposium 27: Why do we gain weight; homeostasis and rewards of ingestive behaviour
Brain systems involved in food intake - a neuroimaging approach
Stefanie Hahner
Stefanie Hahner
S28.1
Tue 31 15:00 Symposium 28: Adrenal Insufficiency: Causes and management
TBC
Cecilia Lindgren
Cecilia Lindgren
S29.3
Tue 31 15:00 Symposium 29: New insights into the pathogenesis of PCOS
Have GWAS studies of PCOS given new insights into its pathogenesis
Steven Russell
Steven Russell
PL6
Tue 31 17:15 Plenary 6
Bionic pancreas
Professor Mirjam Christ-Crain
Mirjam Christ-Crain
S30.1
Tue 31 15:00 Symposium 30: Disorders of development and function of neurohypophysis
Co-peptin in the diagnosis and prediction of diabetes insipidus
Hugo Vankelecom
Hugo Vankelecom
S3.2
Sun 29 10:30 Symposium 3: Senescence and plasticity in the anterior pituitary
Pituitary stem cells: quest for hidden functions
Professor Colin Duncan
Colin Duncan
S29.2
Tue 31 15:00 Symposium 29: New insights into the pathogenesis of PCOS
Energy balance and androgens
Carla Moran
Carla Moran
MTE2.2
Sun 29 08:15 Meet the Expert 2
Difficult thyroid cases
Vasileios Chortis
Vasileios Chortis
OC1.4
Sun 29 12:15 Oral Communications - Adrenal Basic & Clinical
Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma
Aylin Hanyaloglu
Aylin Hanyaloglu
S20.1
Mon 30 15:30 Symposium 20: Hitchhiker's guide to the microsmos of GPCRs
Location, location, location: spatial programming of GPCR signalling
Jenny Visser
Jenny Visser
S29.1
Tue 31 15:00 Symposium 29: New insights into the pathogenesis of PCOS
Metabolic dysfunction in a rodent model of PCOS
TBC
TBC
Sun 29 14:15 Endocrine nurse session 2: Professional development session
Announcement of Best Nursing Poster Award and short presentation by winner
TBC
TBC
S27.3
Tue 31 15:00 Symposium 27: Why do we gain weight; homeostasis and rewards of ingestive behaviour
TBC
James Fagin
James Fagin
S6.1
Sun 29 15:30 Symposium 6: Characterisation and treatment of thyroid cancer
Intergrated genomic characterisation
Sasha Howard
Sasha Howard
S10.3
Sun 29 15:30 Symposium 10: Late Breaking News Session
The Search for Disease-Causing Mutations in Self-Limited Delayed Puberty
Christa Flück
Christa Flück
S28.2
Tue 31 15:00 Symposium 28: Adrenal Insufficiency: Causes and management
Genetics of adrenal insufficiency
Edward Visser
Edward Visser
S11.1
Mon 30 10:30 Symposium 11: New Developments in subclinical thyroid disease
Thyroid function and aging: what can we learn from animal models?
Manuel Tena-Sempere
Manuel Tena-Sempere
S12.3
Mon 30 10:30 Symposium 12: Novel insights of disorders in pubertal timing
Novel regulatory molecules of pubertal timing
Albert Beckers
Albert Beckers
GH1
Sat 28 17:55 Geoffrey Harris Prize Lecture
Beyond the Adenoma Valley: From FIPA to Gigantism and Back
Anna Cariboni
Anna Cariboni
S17.3
Mon 30 15:30 Symposium 17: Genetics and epigenetics of testicular failure
SEMA3A and SEMA3E: from mice to Kallmann syndrome
Cristina Ronchi
Cristina Ronchi
OC1.1
Sun 29 12:15 Oral Communications - Adrenal Basic & Clinical
Genetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg Mutation
Mark Sherlock
Mark Sherlock
S30.2
Tue 31 15:00 Symposium 30: Disorders of development and function of neurohypophysis
Role of TBI in the development of neuropophyseal disorders
Wiebke Arlt
Wiebke Arlt
CETL1
Mon 30 17:30 Clinical Endocrinology Trust Lecture
Adrenal
Professor Richard Anderson
Richard Anderson
S22.3
Tue 31 10:00 Symposium 22: New mechanisms to induce and and protect from ovarian insuffciency
Ovarian protection during cancer treatment
Lora Heisler
Lora Heisler
S27.1
Tue 31 15:00 Symposium 27: Why do we gain weight; homeostasis and rewards of ingestive behaviour
Reward system: the cellular basis
Jason Carroll
Jason Carroll
EJE1
Sat 28 18:45 European Journal of Endocrinology Prize Lecture
Understanding estrogen receptor activity in breast cancer
Monica Dentice
Monica Dentice
S25.1
Tue 31 10:00 Symposium 25: What's new and exciting in nuclear receptor action
Local regulation of TH action in stem cell survival
Andrew Dwyer
Andrew Dwyer
OC13.5
Tue 31 11:45 Oral Communications - Pituitary Clinical
Unmet health and information needs of women with hypogonadotropic hypogonadism
Paul Stewart
Paul Stewart
D4.2
Tue 31 08:15 Debate 4
Should we treat subclinical Cushing’s syndrome?: AGAINST
Laura Gathercole
Laura Gathercole
OC12.2
Tue 31 11:45 Oral Communications - Obesity
Female 5β-Reductase Knockout Mice are Protected from Diet Induced Obesity, Insulin Resistance and Glucose Intolerance
Christina Thirlwell
Christina Thirlwell
S18.1
Mon 30 15:30 Symposium 18: Neuroendocrine tumours: new findings, classification and targeted management
NETs cracking the epigentic code
Marcus Quinkler
Marcus Quinkler
OC1.3
Sun 29 12:15 Oral Communications - Adrenal Basic & Clinical
Hormone replacement therapy with prednisolone is associated with a worse lipid profile than replacement with hydrocortisone in patients with adrenal insufficiency: a matched analysis of data from the EU-AIR
Marcus Quinkler
Marcus Quinkler
Mon 30 14:00 Endocrine nurse session 3: MDT Clinical Symposium 2 – MDT management of Adrenal Insufficiency (AI)
Diagnosis and management of AI and adrenal crisis
Laura Fugazzola
Laura Fugazzola
OC14.3
Tue 31 11:45 Oral Communications - Thyroid Cancer
Tert and The Oxidative Stress In Papillary Thyroid Cancer
Felipe Casanueva
Felipe Casanueva
S4.2
Sun 29 10:30 Symposium 4: How to diagnose endocrine disease in obese patients?
Male hypogonadism and obesity: How to differentiate cause and consequence
Felipe Casanueva
Felipe Casanueva
EH1
Mon 30 09:30 European Hormone Medal Lecture
Obesity
Rosario Pivonello
Rosario Pivonello
S13.2
Mon 30 10:30 Symposium 13: Management of Cushing's syndrome
State of the art treatment in Cushing's disease
Romana Netea-Maier
Romana Netea-Maier
OC14.2
Tue 31 11:45 Oral Communications - Thyroid Cancer
Complex immunometabolic pathways mediate the interaction between thyroid carcinoma cells and tumor-associated macrophages
Sofia Llahana
Sofia Llahana
Sat 28 12:00 ECE pre-congress Nurse Course: Session 1: Diagnosis and treatment
Welcome
Sofia Llahana
Sofia Llahana
Sun 29 14:15 Endocrine nurse session 2: Professional development session
Welcome and update from the ESE Nurses Working Group
Chris Yedinak
Chris Yedinak
Sat 28 14:20 ECE pre-congress Nurse Course: Session 2: Case presentations
The nursing role in longterm follow-up of a patient with acromegaly and in a patient with prolactinoma
Abstract Code Title Authors Affiliations Category
EP1 Establishment and characterization of immortalized porcine 11β HSD1-hepatocytes Hee Young Kang, Jeong Ung Hwang, Myoungho Lee, Jin Yong An, Eui-Bae Jeung Adrenal cortex (to include Cushing’s)
EP2 Effect of heterophilic antibody interference in ACTH immunoassay to Subclinical Cushing’s Syndrome screening: A pilot study Serkan Yener, Seciil Ozisik, Umit Cavdar, Mustafa Demirpence, Abdurrahman Comlekci Adrenal cortex (to include Cushing’s)
EP3 Pro-coagulant imbalance in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors Elisa Verrua, Elisa Sala, Elena Malchiodi, Emanuele Ferrante, Giorgio Arnaldi, Laura Trementino, Armando Tripodi, Fabrizio Semeraro, Concetta T. Ammollo, Mario Colucci, Lidia Padovan, Veena Chantarangkul, Flora Peyvandi, Giovanna Mantovani Adrenal cortex (to include Cushing’s)
EP4 Missed opportunities for appropriate diagnosis and management of profound hyponatraemia – Audit of District General Hospital experience Paris Limin Cai, Christopher James Thomas, Qaiser Zeb, Cosmas Anazodo, Mohamed Malik Adrenal cortex (to include Cushing’s)
EP5 Paradoxical worsening of lipid metabolism after successful treatment of primary aldosteronism. Christian Adolf, Evelyn Asbach, Anna Dietz, Stefanie Hahner, Marcus Quinkler, Lars Christian Rump, Martin Bidlingmaier, Marcus Treitl, Klaus Hallfeldt, Felix Beuschlein, Martin Reincke Adrenal cortex (to include Cushing’s)
EP6 Bilateral adrenalectomy is a safe long-term procedure Moutarde Coralie, Caiazzo Robert, Bauters Catherine, Cortet Christine, Do Cao Christine, Wemeau Jean-Louis, Pattou François, Vantyghem Marie-Christine Adrenal cortex (to include Cushing’s)
EP7 Radiological formula for differentiating between secreting and non secreting adrenal adenomas. Valentina Vicennati, Elena Casadio, Uberto Pagotto, Guido Di Dalmazi, Eleonora Rinaldi, Cristina Mosconi, Dimitris Papadopoulos, Rita Golfieri, Renato Pasquali Adrenal cortex (to include Cushing’s)
EP8 Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes Giuseppe Bellastella, Maria Ida Maiorino, Annamaria De Bellis, Lorenzo Scappaticcio, Katherine Esposito, Dario Giugliano Adrenal cortex (to include Cushing’s)
EP9 The use of [131I] 6β-iodomethyl-norcholesterol scintigraphy in evaluation of adrenal tumors. Lucyna Papierska, Michał Rabijewski, Anna Kamińska, Jarosław Ćwikła, Maciej Otto, Andrzej Cichocki, Radosław Samsel, Wojciech Zgliczyński Adrenal cortex (to include Cushing’s)
EP10 Computerized tomography and magnetic resonance imaging features for differentiating functioning adrenal lesions from non-functioning adrenal lesions Derya Koseoglu, Mazhar Muslum Tuna, Narin Nasiroglu Imga, Bercem Aycicek Dogan, Mehtap Navdar Basaran, Cagdas Senel, Altug Tuncel, Dilek Berker, Serdar Guler Adrenal cortex (to include Cushing’s)
EP11 ARMC5 mutation and Cushing syndrome due to bilateral macronodular adrenal hyperplasia – Case Report Maria Manuel Costa, Joana Oliveira, Jose Luis Castedo, Joao Magalhães, Davide Carvalho Adrenal cortex (to include Cushing’s)
EP12 Nonfuntional Adrenal Incidentalomas and Cardiometabolic Risk Lia Ferreira, Isabel Palma Adrenal cortex (to include Cushing’s)
EP13 Immunohistochemical characteristics of blood vessels in non-visualized and visualized on MRI pituitary adenomas in patients with Cushing’s disease (pilot study). Iya Voronkova, Zhanna Belaya, Patimat Khandaeva, Liudmila Rozhinskaya, Alexander Vorontsov, Ivan Sitkin, Andrey Grigoriev, Galina Melnichenko Adrenal cortex (to include Cushing’s)
EP14 Adrenal crisis and sick day episodes among CAH patients: Preliminary report based on International CAH (I-CAH) registry Nayananjani Karunasena, Eleni Daniel, Jillian Bryce, Jipu Jiang, S.Faisal Ahmed, Tulay Guran, Berenice B Mendonca, Tania A Bachega, Oliver Blankenstein, Birgit Koehler, Uta Neumann, Carlo Acerini, Nils Krone, Walter Bonfig, Klaus Mohnike, Heba Elsedfy, Richard Ross Adrenal cortex (to include Cushing’s)
EP15 Impact of the chemokine receptors CXCR4 and CXCR7 on metastatic potential and survival in adrenocortical carcinoma Irina Chifu, Carmina Fuß, Cristina Ronchi, Katja Marienfeld, Martin Fassnacht, Stefanie Hahner, Britta Heinze Adrenal cortex (to include Cushing’s)
EP16 Adrenal function recovery after adrenalectomy in Cushing syndrome Lidia Radomir, Daniel Mihai, Andra Caragheorgheopol, Victor Tomulescu, Corin Badiu Adrenal cortex (to include Cushing’s)
EP17 Psychopathology, memory and quality of life in Cushing’s syndrome Alicia Santos, Eugenia Resmini, Iris Crespo, Elena Valassi, Mª Antonia Martínez, Patricia Pires, Susan Webb Adrenal cortex (to include Cushing’s)
EP18 CAROTID INTIMA-MEDIA THICKNESS AS THE CARDIOMETABOLIC RISK INDICATOR IN PATIENTS WITH NONFUNCTIONAL ADRENAL MASS AND METABOLIC SYNDROME SCREENING gamze Akkus, Tamer Tetiker, ali Deniz, Mehtap Evran, Murat Sert Adrenal cortex (to include Cushing’s)
EP19 Are adrenal incidentalomas components of metabolic syndrome? Elzbieta Bandurska Stankiewicz, Katarzyna Myszka- Podgórska, Joanna Rutkowska, Wojciech Matuszewski, Rakesh Jalali Adrenal cortex (to include Cushing’s)
EP20 Congenital adrenal hyperplasia– “natural history of the disease” – very late diagnosis in a series of patients. Urszula Ambroziak, Anna Kępczyńska-Nyk, Maja Lenkiewicz-Sidor, Krystian Jażdżewski, Ewa Małunowicz, Tomasz Bednarczuk Adrenal cortex (to include Cushing’s)
EP21 Long-term metabolic evolution of a cohort of patients treated for adrenal insufficiency. Moutarde Coralie, Douillard Claire, Bauters Catherine, Cortet Christine, Do Cao Christine, Leclerc Laurence, Merlen Emilie, Pigny Pascal, Wemeau Jean-Louis, Vantyghem Marie-Christine Adrenal cortex (to include Cushing’s)
EP22 Method-specific serum cortisol responses to the adrenocorticotropin test: comparison of two generations of Roche automated immunoassays using polyclonal versus monoclonal antibodies Marianne Klose, Linda Hilsted, Ulla Feldt-Rasmussen Adrenal cortex (to include Cushing’s)
EP23 Ascending aorta dilatation in primary aldosteronism: a new deleterious consequence of aldosterone excess. Valentina Vicennati, Guido Zavatta, Uberto Pagotto, Elena Casadio, Guido Di Dalmazi, Rinaldi Eleonora, Renato Pasquali Adrenal cortex (to include Cushing’s)
EP24 Identified mutations in CYP11B1 gene in two Tunisian patients with 11-beta hydroxylase deficiency Houda Ennaifer, Ines Kammoun, M Kharrat, Nessrine Cheikrouhou, Maria Khatib, M Trabelsi, Claude Ben Slama Adrenal cortex (to include Cushing’s)
EP25 Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes Charlotte Steffensen, Henrik Holm Thomsen, Olaf M. Dekkers, Jens S. Christiansen, Jørgen Rungby, Jens Otto L. Jørgensen Adrenal cortex (to include Cushing’s)
EP26 Glucocorticoid axis in patients with primary aldosteronism Raluca Trifanescu, Alexandra Smarandoiu, Andra Caragheorgheopol, Sorina Schipor, Anda Dumitrascu, Catalina Poiana Adrenal cortex (to include Cushing’s)
EP27 Bilateral adrenalectomy in Cushing’s syndrome: evaluation of quality of life compared to other treatment options. Pauline Sarkis, Muriel Rabilloud, Anna Siamand, Jean-Christophe Lifante, Olivier Chabre, Gérald Raverot Adrenal cortex (to include Cushing’s)
EP28 Adenoma size could be an important predictor of Subclinical Cushing's Syndrome Serkan Yener, Mustafa Baris, Mustafa Demirpence, Secil Ozisik, Umit Cavdar, Omer Demir, Mustafa Secil, Abdurrahman Comlekci Adrenal cortex (to include Cushing’s)
EP29 LONG TERM FOLOW-UP OF PATIENTS WITH ADRENAL INCIDENTALOMAS AND SUBCLINICAL HYPERCORTISOLISM: A SINGLE CENTER EXPIRIENCE Miomira Ivovic, Ljiljana Marina, Milina Tancic-Gajic, Zorana Arizanovic, Jelena Milin-Lazovic, Dragana Rakovic, Zorana Stojanovic, Aleksandra Paunovic, Svetlana Vujovic Adrenal cortex (to include Cushing’s)
EP30 Do lipid profile predict subclinical Cushing's Syndrome in patients with adrenal incidentalomas? Gesthimani Mintziori, Thomas Georgiou, Athanasios Siolos, Fotini Adamidou, Zoe Efstathiadou, Panagiotis Anagnostis, Athanasios Panagiotou, Marina Kita Adrenal cortex (to include Cushing’s)
EP31 Primary Aldosteronism – results from the first Portuguese multicentre study Tiago Nunes da Silva, Vera Fernandes, Diana Martins, Diana Gonçalves, Raquel Almeida, Ana Margarida Monteiro, Carolina Neves, Helder Simões, Pedro Marques, Filipa Alves, Maria Pereira Adrenal cortex (to include Cushing’s)
EP32 Adrenal pigmentation in PPNAD is a result of melanin deposition and associated with upregulation of the melanocortin 1 receptor Dominic Cavlan, Chris Evagora, Dan Berney, Helen Storr, Will Drake, Peter King Adrenal cortex (to include Cushing’s)
EP33 Androgen producing adenoma in a patient with non-diagnosed congenital adrenal hyperplasia. Mikuláš Kosák, Václav Hána jr., David Michlaský, Jozef Kubinyi, Václav Hána Adrenal cortex (to include Cushing’s)
EP34 Menstrual Function in Women with Cushing’s Disease (CD) Irina Komerdus, Larisa Akulkina, Anastasiia Chekanova, Alexander Dreval Adrenal cortex (to include Cushing’s)
EP35 The Effect of Stress, Diet and Analytical Methods on the Levels of Corticoid Metabolites Michaela Duskova, Lucie Sosvorova, Jana Vitku, Hana Jandikova, Tereza Chlupacova, Jose De Cordeiro, Luboslav Starka Adrenal cortex (to include Cushing’s)
EP36 ADRENOCORTICAL CARCINOMA: SINGLE CENTER EXPERIENCE Pinar Sisman, Ahmet Bilgehan Sahin, Ozen Oz Gul, Soner Cander, Erdinc Erturk, Canan Ersoy Adrenal cortex (to include Cushing’s)
EP37 CYP11B2 polymorphism affects the aldosterone – renin ratio? Lukasz Zukowski, Janusz Mysliwiec, Natalia Wawrusiewicz-Kurylonek, Maria Górska Adrenal cortex (to include Cushing’s)
EP38 Moderate/severe Hypovolemic Hyponatremia with urinary sodium loss secondary to Hypoaldosteronism: analysis of 28 cases Rona Penso, Ana Ortola, Angela Amengual, Irene Crespo, Teresa Ruiz-Gracia, Martin Cuesta-Hernandez, Emilia Gomez-Hoyos, Clara Marcuello, Alfonso Calle, Isabelle Runkle Adrenal cortex (to include Cushing’s)
EP39 The classical form of congenital adrenal hyperplasia- clinical characteristics and genetic analysis. Elwira Przybylik-Mazurek, Anna Kurzynska, Anna Skalniak, Jakub Piatkowski, Alicja Hubalewska-Dydejczyk Adrenal cortex (to include Cushing’s)
EP40 Analysis of 176 cases of adrenal incidentaloma investigated in a single clinical center, what are we doing? MARIA MAIZ JIMENEZ, MARIA CALATAYUD GUTIERREZ, MILAGROS SIERRA BRACAMONTE, SOLEDAD LIBRIZZI, VIRGINIA RODRIGUEZ NIÑO, MYRIAM LORENA PARTIDA MUÑOZ, FEDERICO HAWKINS CARRANZA Adrenal cortex (to include Cushing’s)
EP41 The role of DHEAS in diagnosis of subclinical hypercortisolism in patients with adrenal incidentalomas Ljiljana Marina, Miomira Ivovic, Milina Tancic-Gajic, Zorana Arizanovic, Jelena Milin-Lazovic, Dragana Rakovic, Zorana Stojanovic, Isidora Petkovic, Tijana Petkovic, Svetlana Vujovic Adrenal cortex (to include Cushing’s)
EP42 What can a tissue measured steroid metabolome tell about adrenal tumor? A tissue steroid analysis of cortisol producing adenoma and an androgen producing adenoma in a second patient with CAH, 21-hydroxylase deficiency. Václav Hána jr., Mikuláš Kosák, David Michalský, Václav Hána, Martin Hill Adrenal cortex (to include Cushing’s)
EP43 Primary bilateral diffuse large B-cell lymphoma of adrenals presenting as incidental adrenal masses Cristina Alina Silaghi, Delia Dima, Carmen Georgiu, Delia Lupu, Ionela Lungu, Anca Elena Craciun, Daniel Tudor Cosma, Cristina Sorina Catana, Horatiu Silaghi, Romeo Chira Adrenal cortex (to include Cushing’s)
EP44 A microdeletion of PRKARIA associated with Carney Complex Fotini Adamidou, Gesthimani Mintziori, Charalampos Lyssikatos, Constantine Stratakis Adrenal cortex (to include Cushing’s)
EP45 Prevalence of Primary Hyperaldosteronism as secondary hypertension; our experience. Ergita Nelaj, Margarita Gjata, Ariet Gjika, Mihal Tase Adrenal cortex (to include Cushing’s)
EP46 Ipilimumab immunotheraphy for advanced melanoma induced autoimmune adrenalitis Julia Silva-Fernández, Rafael Morales-Chamorro, Francisco Javier Gómez-Alfonso, Florentino Del Val-Zaballos, Álvaro García-Manzanares-Vázquez de Agredos, María López-Iglesias, Rafael García-Ruiz, Inés Gómez-García Adrenal cortex (to include Cushing’s)
EP47 Cardio metabolic parameters in non-functional adrenal adenoma Alp Atasoy, Evrim Cakir, Suleyman Ahbab, Yasemin Erdogan Doventas, Macit Koldas, Esra Ataoglu, Mustafa Yenigun Adrenal cortex (to include Cushing’s)
EP48 Cushings syndrome due to carneys complex – Case series and a report of a new mutation from South Indian Tertiary care centre kavya Jonnalagadda, Praveen V.P, Nisha bhavani, Jaykumar R.V, Vasantha Nair, Harish Kumar, Arun Menon, Usha Menon Adrenal cortex (to include Cushing’s)
EP49 Cushing’ s Disease, Hasimoto’s Thyroiditis and Severe Hyperandrogenemia Ana Valea, Irina Ciocan, Mara Carsote, Andra Morar, Dan Dumitru Pop, Cristina Ghervan, Carmen Emanuela Georgescu Adrenal cortex (to include Cushing’s)
EP50 Adrenal Infarction in Antiphospholipid Syndrome Despite Therapeutic Anticoagulation Eleanor Wong, Michael Watts, James A O'Hare Adrenal cortex (to include Cushing’s)
EP51 Pediatric Cushing’s Disease and Paraduodenal Tumor Ana Valea, Maria Breaban, Mara Carsote, Andra Morar, Dan Dumitru Pop, Carmen Emanuela Georgescu, Cristina Ghervan Adrenal cortex (to include Cushing’s)
EP52 Adrenal Leiomyoma: a rare cause of adrenal incidentaloma Maria Manuel Costa, Sandra Belo, Pedro Souteiro, Joao Magalhães, Davide Carvalho Adrenal cortex (to include Cushing’s)
EP53 Ectopic expression of Serotonin receptors in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Saad Ghada, Chadli Molka, Dendana Emna, Hasni Yosra, Maaroufi Amel, Kacem Maha, Ach Kousay Adrenal cortex (to include Cushing’s)
EP54 Cushing’s Syndrome in King Chulalongkorn Memorial Hospital: Experience from a single tertiary referral hospital Wasita Warachit, Sarat Sunthornyothin Adrenal cortex (to include Cushing’s)
EP55 Outcome with surgical treatment in subclinical hypercortisolism Cristina Moreno, Miguel Paja, Alba Zabalegui, Maddalen Dublang, Eider Etxeberria, Amelia Oleaga, M Teresa Gutiérrez Adrenal cortex (to include Cushing’s)
EP56 Addison’s disease warrants large package of care costs due to substantial comorbidity Ian Louis Ross, Cara Biden, Rory Leisegang Adrenal cortex (to include Cushing’s)
EP57 Testosterone and cortisol co-secretion by an adrenocortical adenoma presenting as secondary polycythemia Fotini Adamidou, Gesthimani Mintziori, Efthymia Vlahaki, Apostolos Kambaroudis Adrenal cortex (to include Cushing’s)
EP58 Endosonography – an important diagnostic tool in identifying a small aldosterone-producing adenoma in a patient with primary hyperaldosteronism – case report – Simona Raluca Bergmann, Peter Herbert Kann Adrenal cortex (to include Cushing’s)
EP59 Retrospective Evaluation of Adrenal Incidentelomas Ahmet Kaya, Mustafa Kulaksizoglu, Melek Caglayan, Feridun Karakurt Adrenal cortex (to include Cushing’s)
EP60 PRIMARY HYPERALDOSTERONISM: CLINICAL AND THERAPEUTIC APPROACH OF A CENTER Diana Martins, Carolina Moreno, Carla Baptista, Isabel Paiva, Daniela Guelho, Nuno Vicente, Luís Cardoso, Diana Oliveira, Adriana Lages, Mara Ventura, Francisco Carrilho Adrenal cortex (to include Cushing’s)
EP61 Circadian rhythm of salivary cortisol & 6 –sulfatoxy melatonin in night shift nursing professionals and actual day workers B Anjum, Narsingh Verma, Sandeep Tiwari, Ranjana Singh, Abbas Mahdi Adrenal cortex (to include Cushing’s)
EP62 A case of subclinical primary aldosteronism and subclinical Cushing’s syndrome without risk factors of cardiovascular disease Natsumi Kitajima, Toshiro Seki, Atsushi Yasuda, Masami Seki, Masayuki Oki, Atsushi Takagi, Masafumi Fukagawa Adrenal cortex (to include Cushing’s)
EP63 The relationship between androgen levels and NLR in hirsutism Samet Sayılan, Meral Mert, Aylin Aydın Sayılan, Ebru Ozturk, Yildiz Okuturlar, Hakan Kocoglu Adrenal cortex (to include Cushing’s)
EP64 ACTH-independent massive bilateral macronodular adrenal hyperplasia Rosa Márquez-Pardo, M Gloria Baena-Nieto, Lourdes García-García-Doncel, Manuel Cayón-Blanco, Rosario López-Velasco, Isabel Torres-Barea Adrenal cortex (to include Cushing’s)
EP65 Schmidt's syndrome – Case report Entela Puca, Blertina Olldashi, Ema Lumi, Sonila Bitri, Agron Ylli Adrenal cortex (to include Cushing’s)
EP66 IATROGENIC CUSHING’S SYNDROME DUE TO MISUSE OF TOPICAL CORTICOSTEROIDS: A CASE REPORT Emre Ali Acar, Emel Senol, Sena Ece Davarci, Neslihan Erdem, Zeliha Hekimsoy Adrenal cortex (to include Cushing’s)
EP67 Non-Hodgkins B Cell Lymphoma Presenting as Acute Adrenal Crisis Eleanor Wong, James A O'Hare Adrenal cortex (to include Cushing’s)
EP68 The frequency of tissue transglutaminase antibodies in the monoglandular and polyglandular autoimmune endocrine disorders Aysen Akkurt Kocaeli, Soner Cander, Ozen Oz Gul, Pinar Sisman, Canan Ersoy, Erdinc Erturk Adrenal cortex (to include Cushing’s)
EP69 HYPERPARATHYROIDISM HEALING IN PATIENTS TREATED FOR HYPERALDOSTERONISM: 3 CASES Lourdes Garcia blasco, Juan Carlos Ferrer Garcia, Mercedes Tolosa Torrens, Pablo Sanz revert, Cristian Marco Alacid, Carlos Sánchez Juan Adrenal cortex (to include Cushing’s)
EP70 Large Aortic Aneurism and Left Coronary Artery Calcifications: Incidental Findings at Adrenal Incidentaloma Assessment Mara Carsote, Mariana Dobrescu, Anda Dumitrascu, Adriana Gruia, Ana Valea, Adina Ghemigian Adrenal cortex (to include Cushing’s)
EP71 From mild abdominal pain to large right adrenal cyst Dana Moraru, Corina Chirita, Simona Tataru, Ioana Trandafir, Mara Carsote, Ana Valea, Razvan Petrescu Adrenal cortex (to include Cushing’s)
EP72 ADRENAL FAILURE SECONDARY TO BILATERAL ADRENAL METASTASIS AS A PRESENTING FEATURE OF LUNG CANCER: A CASE REPORT OSMAN SUTCUOGLU, BASAK BOLAYIR, MUHITTIN YALCIN, HASAN SATIS, ALEV ALTINOVA, MUJDE AKTURK, FUSUN BALOS TORUNER, NURI CAKIR Adrenal cortex (to include Cushing’s)
EP73 CLINICAL CASE OF YATROGENIC HYPERCORTISOLISM IN PREGNANT WOMAN WITH ADRENAL INSUFFICIENCY Natalya Volkova, Mariya Porksheyan, Saida Kanaeva, Ilya Davidenko Adrenal cortex (to include Cushing’s)
EP74 ADRENAL INSUFFICIENCY DUE TO X-LINKED ADRENOLEUKODYSTROPHY DIAGNOSED IN LATE ADULTHOOD María Soledad Gogorza Pérez, Guillermo Serra Soler, Ana Jimenez Portilla, Marzena Wos, Honorato García Fernández, Iñaki Argüelles Jiménez, Santiago Tofé Povedano, Mercedes Codina Marcet, Elena Mena Ribas, Vicente Pereg Macazaga Adrenal cortex (to include Cushing’s)
EP75 MASSIVE BILATERAL PHEOCROMOCYTOMAS: A RARE CASE Diana Martins, Dírcea Rodrigues, Carla Baptista, Miguel Melo, Luís Cardoso, Nuno Vicente, Diana Oliveira, Mara Ventura, Adriana Lages, Francisco Carrilho Adrenal cortex (to include Cushing’s)
EP76 A Rare Case of Ectopic ACTH Syndrome Originated from Malignant Renal Paraganglioma Esra Tutal, Demet Yılmazer, Taner Demirci, Erman Cakal, evrim Cakir, Bahadir Celep, Oya Topaloglu, Tuncay Delibasi Adrenal cortex (to include Cushing’s)
EP77 Adrenal venous sampling is useful for a definitive diagnosis in Cushing’s syndrome with bilateral adrenal tumors Toshiro Seki, Atsushi Yasuda, Natsumi Kitajima, Masami Seki, Masayuki Oki, Atsushi Takagi, Masafumi Fukagawa Adrenal cortex (to include Cushing’s)
EP78 Non functional unilateral giant adrenal myelolipoma: A case report Ferhat Gokay, Yasin Simsek, Tamer Ertan, Ebru Akay Adrenal cortex (to include Cushing’s)
EP79 Large bilateral adrenal metastatic melanoma Blertina Dyrmishi, Taulant Olldashi, Elvana Rista, Eneida Hoxha, Entela Puca, Thanas Fureraj, Agron Ylli Adrenal cortex (to include Cushing’s)
EP80 Cushing syndrome with ectopic secretion of ACTH by a lung carcinoma. Elena Moravčíková, Michal Kulich, Helena Urbánková, Juliana Gregová, Peter Vaňuga Adrenal cortex (to include Cushing’s)
EP81 Asynchronous Bilateral Adrenal Masses: from Surgery to Endocrine Follow-up Ana Valea, Irina Ciocan, Dan Dumitru Pop, Mara Carsote, Iulia Muntean, Cristina Ghervan, Carmen Emanuela Georgescu Adrenal cortex (to include Cushing’s)
EP82 ADRENOCORTICAL CARCINOMA. REPORT OF 4 CASES MARIANA TOMÉ FERNÁNDEZ-LADREDA, GUILLERMO MARTÍNEZ DE PINILLOS, FERNANDO GARCÍA Adrenal cortex (to include Cushing’s)
EP83 Depression and Acute kidney injury – unusual presentation of Addison’s disease. Sajjad Ahmad, Naveed Khalily, Petros Vernavos, Laxmi Narsimharao Bondugulapati Adrenal cortex (to include Cushing’s)
EP84 Pheochromocytoma/paraganglioma: Histopathological features as clue to the underlying germline mutation in these genetically heterogeneous tumors MAITRAYEE ROY, SHIPRA AGARWAL, MEHAR CHAND SHARMA, POONAM GUPTA, M.L. KHURANA, RAJESH KHAGAWAT, NIKHIL TANDON Adrenal medulla
EP85 Clinical review of patients with pheochromocytoma diagnosed between 2011-2015 Maria Kurowska, Anna Oszywa-Chabros, Joanna Malicka, Jerzy S. Tarach Adrenal medulla
EP86 Diagnostic tools for incidental pheochromocytoma and paraganglioma Akiyuki Kawashima, Kentaro Okamoto, Aya Amano, Hiroyuki Murabe, Toshihiko Yokota Adrenal medulla
EP87 Importance of long term follow up in pheochromocytoma Dhiya eddine Bellarbi, Said Azzoug, Leyla Rabehi, Farida Chentli Adrenal medulla
EP88 High prevalence of germinal mutations in pheochromocytomas with normal urinary metanephrines results João Silva, Susana Prazeres, Rita Domingues, Ana Font, Valeriano Leite Adrenal medulla
EP89 A Novel RET mutation presented with VHL disease-like clinical manifestation Euidal Jung, EonJu Jeon Adrenal medulla
EP90 A case of ectopic Cushing syndrome due to pheocromositoma Askin Gungunes, Senay Arikan Durmaz, Aydin Cifci, Esra Erden, Merve Tas, Selim Yalcin Adrenal medulla
EP91 Neurofibromatosis type 1 associated with pheochromocytoma Tensim Slim, Manel Jemel, Hanen Sayadi, Hela Marmouch, Sameh Graja, Ines Khochtali Adrenal medulla
EP92 CLINICAL CASE OF GIANT PHEOCHROMOCYTOMA WITH LOW HORMONAL ACTIVITY Natalya Volkova, Dmitriy Beltsevitch, Mariya Porksheyan, Saida Kanaeva, Ilya Davidenko Adrenal medulla
EP93 HYPERTENSION AND HYPOKALEMIA IN A 56 YEAR-OLD MALE Sara Quintana-Arroyo, Carmen Acosta-Calero, Claudia Arnas-Leon, Ana-Delia Santana-Suarez, Francisco-Javier Martinez-Martin Adrenal medulla
EP94 Asymptomatic “giant” pheochromocytoma discovered as adrenal incidentaloma Danijela Radojkovic, Milan Radojkovic, Milica Pesic, Sonja Kostic, Sanja Curkovic, Sasa Radenkovic, Slobodan Antic, Ivan Ilic Adrenal medulla
EP95 An unusual Phaeochromocytoma P Kumar, A Rees, DE Price Adrenal medulla
EP96 Usefulness of assessment of urinal metoxycatecholamines secretion in everyday clinical practice - Pheochromocytoma as diagnostic challenge. Elwira Przybylik-Mazurek, Ewelina Rzepka, Monika Buziak-Bereza, Alicja Hubalewska-Dydejczyk Adrenal medulla
EP97 Impact of Laboratory assays on the diagnosis of Hyperparathyroidism Hans G Schneider, Joel Smith, Cherie Chiang, Dulani Kottachachchi, Shantanu Joglekar, Chris Bain Bone & Osteoporosis
EP98 From EFOS to ExFOS, active treatment phase. Similarities and differences of the Greek cohorts’ results. Kyriakos Aloumanis, Panagiotis Kokkoris, Andreas Kleisiounis, Evanthia Kofini, Konstantinos Karachalios, Vangelis Drossinos, Georgios Kapetanos Bone & Osteoporosis
EP99 Vertebral and non-vertebral low-traumatic fractures in patients with type 2 diabetes mellitus (T2DM). Tatiana Yalochkina, Zhanna Belaya, Liudmila Rozhinskaya, Michail Antciferov, Larisa Dzeranova, Marina Shestakova, Galina Melnichenko Bone & Osteoporosis
EP100 Osteoporosis and osteopenia in older Emirati men with type 2 diabetes mellitus Raya A Almazrouei, Fatima M Alkaabi, Heba El Gayar, Nader Lessan, Maha T Barakat Bone & Osteoporosis
EP102 A RARE CAUSE OF HYPOCALCAEMIA: PSEUDOHYPOPARATHYROIDISM Gulay Alp, Nilufer Ozdemir Kutbay, Banu Sarer Yurekli, Emin Karaca, Mehmet Erdogan, Sevki Cetinkalp, Gokhan Ozgen, Ferda Ozkinay, Fusun Saygili Bone & Osteoporosis
EP103 Association between household size, residential area, and osteoporosis: Analysis of 2008−2011 KNHANES Sung-Woo Kim, Kwi-Hyun Bae, Jae-Han Jeon, Yeon-Kyung Choi, Mi-Kyung Kim, Hye-Soon Kim, Hyun-Ae Seo, Eui Hyun Kim, Keun-Gyu Park Bone & Osteoporosis
EP104 ASSOCIATION OF VITAMIN D RECEPTOR GENE WITH DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH HYPOTHYROIDISM Ivan Pankiv Bone & Osteoporosis
EP105 A rare differetial diagnosis of Paget's disease BERRIN CETINARSLAN, ALEV SELEK, ZEYNEP CANTURK, ILHAN TARKUN, OZLEM ZEYNEP AKYAY, NAGIHAN AKKAS Bone & Osteoporosis
EP106 AN UNCOMMON REASON OF OSTEOPOROSIS: SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA (SEDC) Onur Elbasan, Pinar Sisman, Aybuke Muti, Ozen Oz Gul, Soner Cander, Erdinc Erturk, Canan Ersoy Bone & Osteoporosis
EP107 Bone microarchitecture assessed by trabecular bone score (TBS) in liver transplants with New-Onset Diabetes after transplantation (NODAT) Maria Soledad Librizzi, Gonzalo Allo, Milagros Sierra, Mercedes Aramendi, Sonsoles Guadalix, Carlos Jimenez, Guillermo Martinez Diaz-Guerra, Federico Hawkins Bone & Osteoporosis
EP108 Serum leptin, adiponectin and ghrelin concentrations in post-menopausal women: is there an association with bone mineral density? Vasilios Mpalaris, Panagiotis Anagnostis, Athanasios Anastasilakis, Dimitrios Goulis, Argyrios Doumas, Ioannis Iakovou Bone & Osteoporosis
EP109 Bone turnover markers in women with postmenopausal osteoporosis depending on the level of vitamin D Jovanka Novakovic-Paro, Tijana Icin, Milena Mitrovic, Dragana Tomic-Naglic, Radoslav Pejin, Djordje Popovic, Ivana Bajkin, Bojan Vukovic, Damir Benc, Milica Medic-Stojanoska, Branka Kovacev-Zavisic Bone & Osteoporosis
EP110 Clinical Characteristics of Paget Disease of Bone from Turkey Dilek Gogas Yavuz, Semra Aytürk, Firat Bayraktar, Sevki Cetinkalp, PD Study Group Bone & Osteoporosis
EP111 Association of bone mineral density with DXA-determined adipose tissue volume and concentrations of selected hormones in young adult women Elzbieta Sowinska-Przepiera, Elzbieta Andrysiak-Mamos, Justyna Syrenicz, Anhelli Syrenicz Bone & Osteoporosis
EP112 Relationships between body composition components in women with anorexia nervosa Inga Aleknaite, Brigita Baks, Marija Tamulaitiene, Vidmantas Alekna, Virginijus Sapoka Bone & Osteoporosis
EP113 IS CARBONHYDRATE INTAKE A RISK FACTOR FOR POSTMENOPAUSAL SPINAL OSTEOPOROSIS? Duygu Kurtulus, Ayse Humeyra Bicer, Hatice Selcen Bicer, Muzaffer Ilhan Bone & Osteoporosis
EP114 BONE DENSITY IN THE HIP AND THE LUMBAR SPINE IN HEALTHY MALE POPULATION Panagiotis Kokkoris, Ioannis Hatzidakis, Eleftherios Hatzelis, Polyzois Makras, Georgios Toloumis Bone & Osteoporosis
EP115 The effect of anorexia nervosa on bone Nuno Vicente, Dírcea Rodrigues, Luísa Barros, Daniela Guelho, Luís Cardoso, Diana Oliveira, Diana Martins, Mara Ventura, Adriana Lages, Francisco Carrilho Bone & Osteoporosis
EP116 The influence of osteoporosis and cardiometabolic syndrome risk factors on bone mineral density in females with thyroid dysfunction Zoran Gluvic, Vladimir Samardzic, Milena Lackovic, Jelena Tica Jevtic, Marina Vujovic, Vesna Popovic-Radinovic, Bojan Mitrovic, Marija Popin-Taric, Anita Vasic-Vlaisavljevic, Esma R. Isenovic Bone & Osteoporosis
EP117 Use of Denosumab for Treatment of Osteoporosis at a Tertiary Referral Centre: An Evaluation According to the UK National Institute of Health and Care Excellence (NICE) Guidelines Seifeldin Yahia, A.M. Roji, Roberto Ledda, Chioma Chilaka, Kamal Chokkalingam, P.J. Prinsloo, H. Divyateja Bone & Osteoporosis
EP118 Incident fragility fractures under antiresorbtive therapy in a 76 year old lady: never too late to discover new causes Amalia Ioana Arhire, Cornelia Tudose, Suzana Florea, Carmen Gabriela Barbu Bone & Osteoporosis
EP119 Thyroid and Parathyroid Secretion Disorders in Senile Osteoporosis Branka Arsenovic, Miljanka Vuksanovic, Teodora Beljic-Zivkovic Bone & Osteoporosis
EP120 Hypophosphatasia. A novel mutation. Gema López Gallardo, Carlos Roa Llamazares Bone & Osteoporosis
EP121 Anorexia nervosa: beyond psychiatry Nuno Vicente, Dírcea Rodrigues, Luísa Barros, Daniela Guelho, Luís Cardoso, Diana Martins, Diana Oliveira, Adriana Lages, Mara Ventura, Lígia Fonseca, Júlia Figueiredo, Francisco Carrilho Bone & Osteoporosis
EP122 Osteoporosis therapy with denosumab in patients after solid organ transplantation. Jana Brunova, Simona Kratochvilova, Josef Bruna Bone & Osteoporosis
EP123 Osteoporosis as a side effect of antineoplastic therapy Joan El Hajj Sleiman, Dan Jinga, Cornelia Nitipir, Carmen Gabriela Barbu Bone & Osteoporosis
EP124 Bone mineralization and hormonal status in Turner syndrome patients: cross sectional one population study Raimonda Klimaite, Ruta Kriksciuniene, Birute Zilaitiene, Rasa Verkauskiene Bone & Osteoporosis
EP125 Osteoporosis in a cohort of 1062 postmenopausal women aicha bouzid, djamila meskine Bone & Osteoporosis
EP126 Osteoporosis and type 2 diabetes djamila meskine, aicha bouzid Bone & Osteoporosis
EP127 State of bone mineral density in children with Turner Syndrome in Ukraine. Nataliya Zelinska, Iryna Shevchenko, Evgenia Globa Bone & Osteoporosis
EP128 Osteocalcin as a marker of bone metabolism disorders in girl with Turner syndrome. Nataliya Zelinska, Iryna Shevchenko, Evgenia Globa Bone & Osteoporosis
EP129 Adrenal Tumors in Menopause: Bone Assessment Adina Ghemigian, Mara Carsote, Anda Dumitrascu, Nicoleta Dumitru, Ana Valea, Gabriela Voicu, Constantin Dumitrache Bone & Osteoporosis
EP130 LONG-TERM USE OF STEROID AND SECONDARY OSTOPOROSIS TO MULTIPLE DISPLACED METATARSAL STRESS FRACTURE: WITH RHEUMATOID ARTHRITIS A CASE REPORT Esra Demirel, Kenan Çadırcı, Kadri Yıldız Bone & Osteoporosis
EP131 BARRETT’S ESOPHAGUS AND OSTEOPENIA. REPORT OF A CASE Panagiotis Athanassiou, Aikaterini Tzanavari, Anestis Spyridis, Markos Kostopoulos, Eleni Xanthakou, Ifigenia Kostoglou-Athanassiou Bone & Osteoporosis
EP132 Osteoporosis and Recurrent Pathological Fractures Associated with Intense Cannabinoid Use: A Case Report Goknur Yorulmaz, Emel Gonullu, Nazim Karakus Bone & Osteoporosis
EP133 Pagetʼ s Disease of Bone - Case Report and a Review of Epidemiology, Pathophysiology and Management Pop Radu Cristina Corina Bone & Osteoporosis
EP134 Depression, Obesity, and Elbow Fracture: a Pathogenic Triangle? Mara Carsote, Valentin Radoi, Ana Valea, Simona Elena Albu, Cristina Vasiliu, Adina Ghemigian Bone & Osteoporosis
EP135 From Pseudohypoparathyroidism to inactivating PTH/PTHrP Signaling Disorder (iPPSD), a novel classification proposed by the European EuroPHP-network Susanne Thiele, Giovanna Mantovani, Anne Barlier, Valentina Boldrin, Paolo Bordogna, Francesca Elli, Kathleen Freson, Intza Garin, Patrick Hanna, Benedetta Izzi, Olaf Hiort, Beatriz Lecumberri, Arrate Pereda, Luisa De Sanctis, Vrinda Saraff, Serap Turan, Alessia Usardi, Ralf Werner, Guiomar Perez de Nanclares, Agnès Linglart Calcium & Vitamin D metabolism
EP136 Vitamin D deficiency in pregnancy associates with increased emotional and behavioral problems at preschool age: the Rhea pregnancy cohort, Crete, Greece Vasiliki Daraki, Theano Roumeliotaki, Georgia Chalkiadaki, Andrew Margioris, Katerina Koutra, Marianna Katrinaki, Andriani Kyriklaki, Mariza Kampouri, Stathis Papavasiliou, Manolis Kogevinas, Leda Chatzi Calcium & Vitamin D metabolism
EP137 Mass Spectrometry coupled with Liquid Chromatography (HPLC-MS-MS) levels of 25-hydroxy vitamin D (25OHVitD) are associated with prognostic markers of Heart Failure Federica Saponaro, Alessandro Saba, Sabina Frascarelli, Claudio Marcocci, Filomena Cetani, Claudio Passino, Riccardo Zucchi Calcium & Vitamin D metabolism
EP138 Increasing incidence of parathyroid carcinoma – a nationwide study Eeva M. Ryhänen, Helena Leijon, Saara Metso, Eija Eloranta, Pirkko Korsoff, Leo Niskanen, Petteri Ahtiainen, Päivi Kekäläinen, Marjo Tamminen, Raija Ristamäki, Otto Knutar, Eliisa Löyttyniemi, Ilkka Heiskanen, Matti J. Välimäki, Caj Haglund, Johanna Arola, Camilla Schalin-Jäntti Calcium & Vitamin D metabolism
EP139 Similarities in Postsurgical vs Nonsurgical Patients With Hypoparathyroidism: Post Hoc Analysis From Recombinant Human Parathyroid Hormone (rhPTH[1-84], Parathyroid Hormone rDNA) REPLACE Study Maria Luisa Brandi, John P. Bilezikian, Bart L. Clarke, William Fraser, Alan Krasner, Hjalmar Lagast, Benjamin Li, Michael Mannstadt, Lars Rejnmark, Dolores M. Shoback, Tamara J. Vokes Calcium & Vitamin D metabolism
EP140 Familial Hypocalciuric hypercalcemia secondary to a novel mutation causing severe hypercalcemia. Natasha Shrikrishna, Syuhada Mohamed, Maeve Middleton, Stephen Wong Calcium & Vitamin D metabolism
EP141 Idiopathic infantile hypercalcemia: presenting in childhood, diagnosed in adulthood – case report Catarina Silvestre, Raquel Paixão, José Maria Aragüés, Sílvia Guerra, Mário Mascarenhas Calcium & Vitamin D metabolism
EP142 Atypical cases of Familial hypocalciuric hypercalcemia: Utility of genetic testing in the diagnosis. Fernando García, Guillermo Martínez de Pinillos, Mariana Tomé, Ignacio Fernández, Ignacio Fernández, Eyvee Arturo Cuéllar, José Álvaro Romero, Juan Manuel García de Quirós, María Victoria Cózar Calcium & Vitamin D metabolism
EP143 Sensitivity of localization studies performed by various radiologists whom are not precisely experienced in the evaluation parathyroid lesions Pinar Sisman, Ozen Oz Gul, Coskun Demirtas, Aybuke Muti, Onur Elbasan, Ozlem Saraydaroglu, Soner Cander, Canan Ersoy, Erdinc Erturk Calcium & Vitamin D metabolism
EP144 Bone Mineral Density is Associated with Hypercalciuria in Primary Hiperparathyroidism Dilek Gogas Yavuz, Bahar Tekin, F.Buket Bayram, M.Melin Uygur Calcium & Vitamin D metabolism
EP145 Bone Mineral Density Measurement in Newly Diagnosed Primary Hyperparathyroidism Patients Bahar Tekin, M.Melin Uygur, F.Buket Bayram, Dilek Gogas Yavuz Calcium & Vitamin D metabolism
EP146 Serum calcium to phosphorous ratio (Ca/P) as a simple, inexpensive screening tool in the diagnosis of primary hyperparathyroidism (PHPT) Bruno Madeo, Elda Kara, Katia Cioni, Silvia Vezzani, Manuela Simoni, Vincenzo Rochira Calcium & Vitamin D metabolism
EP147 Vitamin D status in infants during the first 9 months of age and its effect on growth and other biochemical markers: A Prospective Cohort Study MANISH GUTCH, UDAY MANDAL, SUKRITI KUMAR Calcium & Vitamin D metabolism
EP148 New onset of epileptic seizures induced by Fahr`s syndrome secondary to idiopatic hypoparathyroidism. Cristina Alina Silaghi, Carmen Emanuela Georgescu, Cristina Ghervan, Ana Valea, Ramona Irimia, Daniel Tudor Cosma, Sanda Petrus, Alina Filip, Horatiu Silaghi, Vasile Tibre Calcium & Vitamin D metabolism
EP149 Investigation of vitamin d deficiency in autoimmune endocrine disease in terms of frequency and causal or consequential relationship Aysen Akkurt Kocaeli, Pinar Sisman, Soner Cander, Ozen Oz Gul, Canan Ersoy, Erdinc Erturk Calcium & Vitamin D metabolism
EP150 Vitamin D status in a HIV-infected cohort from south of Spain: descriptive analysis Carolina García-Figueras Mateos, Manuel Cayón Blanco, Patricia Bancalero Herrera, Alberto Terrón Pernía Calcium & Vitamin D metabolism
EP151 Metabolic changes in vitamin D deficiency Ludmila Rozhinskaya, Alexandra Petrushkina, Ekaterina Pigarova, Tatyana Tarasova, Alexander Ilyin Calcium & Vitamin D metabolism
EP152 Calcium as a marker of metabolic decompensation in Glycogen Storage Disease Type-1a Suleyman Nahit Sendur, Ugur Unluturk, Selcuk Dagdelen Calcium & Vitamin D metabolism
EP153 Vitamin D3 deficiency and secondary hyperparathyroidism development in patients with different stages of chronic kidney disease Natalia Karlovich Calcium & Vitamin D metabolism
EP155 Biochemical and hormonal alterations in women who underwent total thyroidectomy. Kassiani Kakava, Symeon Tournis, Georgios Papadakis, Ioannis Karelas, Pavlos Stampouloglou, Evanthia Kassi, Ioannis Triantafillopoulos, Theodoros Karatzas, Vassiliki Villiotou, Nikolaos Dogkas, Pavlos Sarov, Georgios Tassopoulos, Nikolaos Petridis Calcium & Vitamin D metabolism
EP156 Association of serum calcium concentrations with fibrinogen and homocysteine in non-diabetic Korean subjects Eun Sook Kim, Sung Dae Moon, Je Ho Han Calcium & Vitamin D metabolism
EP157 Bone mineral density in postmenopausal women with high levels of parathyroid hormone Irfan Esen, Selin Akturk Esen, Soner Cander, Ozen Oz Gul, Erdinc Erturk Calcium & Vitamin D metabolism